MST3
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | T455 | Sugiyama | SHTN1 KIAA1598 | KPESSKGCEsAVDELKGILGtLNKSTSSRsLKsLDPENsEt |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| B2RPK0 | S15 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHSDAS |
| B2RPK0 | T22 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHSDASVNFSEFS |
| O00267 | T709 | Sugiyama | SUPT5H SPT5 SPT5H | GGSGGMSRGRGRRDNELIGQtVRISQGPYKGYIGVVKDATE |
| O00506 | T166 | Sugiyama | STK25 SOK1 YSK1 | VLLsEQGDVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEV |
| O00506 | T168 | Sugiyama | STK25 SOK1 YSK1 | LsEQGDVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEVIK |
| O00584 | T120 | Sugiyama | RNASET2 RNASE6PL | VIHSFPNRSRFWKHEWEKHGtCAAQVDALNSQKKYFGRSLE |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14908 | T238 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | FDMISQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPs |
| O14908 | T242 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | SQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPsAFEE |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O15212 | T75 | Sugiyama | PFDN6 HKE2 PFD6 | VVFKLLGPVLVKQELGEARAtVGKRLDyItAEIKRYESQLR |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43242 | T69 | Sugiyama | PSMD3 | GEADGKtAAAAAEHsQRELDtVtLEDIKEHVKQLEKAVSGK |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43707 | S507 | Sugiyama | ACTN4 | DsHNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAID |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43707 | T69 | Sugiyama | ACTN4 | EKQQRKTFTAWCNsHLRKAGtQIENIDEDFRDGLKLMLLLE |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60231 | T110 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | LLEKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRKHLRK |
| O60361 | T88 | Sugiyama | NME2P1 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60506 | T348 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DPDPEVMAKVKVLFVRNLANtVTEEILEKAFsQFGKLERVK |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60739 | T72 | Sugiyama | EIF1B | DDyDKKKLVKAFKKKFACNGtVIEHPEyGEVIQLQGDQRKN |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75347 | S103 | Sugiyama | TBCA | ENEKDLEEAEEyKEARLVLDsVKLEA_______________ |
| O75369 | T907 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTYGGD |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75683 | T232 | Sugiyama | SURF6 SURF-6 | SKAQRRKEKRQRVKGNLtPLtGRNYRQLLERLQARQSRLDE |
| O75821 | S217 | Sugiyama | EIF3G EIF3S4 | PGELEPVQAtQNKtGKYVPPsLRDGAsRRGESMQPNRRADD |
| O75821 | T206 | Sugiyama | EIF3G EIF3S4 | LGLstGEKEKLPGELEPVQAtQNKtGKYVPPsLRDGAsRRG |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O75822 | T33 | Sugiyama | EIF3J EIF3S1 PRO0391 | sWDADAFsVEDPVRKVGGGGtAGGDRWEGEDEDEDVKDNWD |
| O76021 | S314 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | RNFEKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKKPE |
| O76021 | T328 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | QARKtAsVLsKDDVAPEsGDtTVKKPESKKEQtPEHGKKKR |
| O76021 | T45 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | PTARKQLDKEQVRKAVDALLtHCKSRKNNYGLLLNENESLF |
| O94776 | T453 | Sugiyama | MTA2 MTA1L1 PID | sLsPyttsANRAKLLAKNRQtFLLQtTKLTRLARRMCRDLL |
| O94776 | T458 | Sugiyama | MTA2 MTA1L1 PID | ttsANRAKLLAKNRQtFLLQtTKLTRLARRMCRDLLQPRRA |
| O95071 | T119 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | GRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsGVGGs |
| O95373 | T997 | Sugiyama | IPO7 RANBP7 | yQALTHGLNEEQRKQLQDIAtLADQRRAAHESKMIEKHGGY |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00492 | S162 | Sugiyama | HPRT1 HPRT | TMQTLLSLVRQYNPKMVKVAsLLVKRTPRSVGYKPDFVGFE |
| P00492 | T124 | Sugiyama | HPRT1 HPRT | sYCNDQsTGDIKVIGGDDLstLTGKNVLIVEDIIDTGKTMQ |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T369 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | ARGTKALMDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKV |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P02786 | T336 | Sugiyama | TFRC | FNHTQFPPSRSSGLPNIPVQtISRAAAEKLFGNMEGDCPSD |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04083 | T226 | Sugiyama | ANXA1 ANX1 LPC1 | LyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKH |
| P04083 | T64 | Sugiyama | ANXA1 ANX1 LPC1 | PssDVAALHKAIMVKGVDEAtIIDILtKRNNAQRQQIKAAY |
| P04083 | T70 | Sugiyama | ANXA1 ANX1 LPC1 | ALHKAIMVKGVDEAtIIDILtKRNNAQRQQIKAAYLQEtGK |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T104 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | KIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKRVIIsAP |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04406 | T99 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | ERDPsKIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKRV |
| P04632 | T143 | Sugiyama | CAPNS1 CAPN4 CAPNS | ILNKVVTRHPDLKTDGFGIDtCRSMVAVMDSDTTGKLGFEE |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06703 | S46 | Sugiyama | S100A6 CACY | KHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRNKDQ |
| P06703 | T43 | Sugiyama | S100A6 CACY | EGDKHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRN |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | S247 | Sugiyama | GPI | EWFLQAAKDPSAVAKHFVALstNttKVKEFGIDPQNMFEFW |
| P06744 | T250 | Sugiyama | GPI | LQAAKDPSAVAKHFVALstNttKVKEFGIDPQNMFEFWDWV |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P06748 | S260 | Sugiyama | NPM1 NPM | GPssVEDIKAKMQAsIEKGGsLPKVEAKFINyVKNCFRMtD |
| P06899 | S39 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07686 | T474 | Sugiyama | HEXB HCC7 | ISYGQDWRKyyKVEPLDFGGtQKQKQLFIGGEACLWGEYVD |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07814 | T745 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVR |
| P07814 | Y1512 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | GAKCVCGKNPAKyytLFGRsy____________________ |
| P07858 | T95 | Sugiyama | CTSB CPSB | TEDLKLPAsFDAREQWPQCPtIKEIRDQGSCGSCWAFGAVE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S623 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tyGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsII |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | T109 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LtIVDtGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P07900 | T624 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIE |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P08195 | S253 | Sugiyama | SLC3A2 MDU1 | FQGHGAGNLAGLKGRLDyLssLKVKGLVLGPIHKNQKDDVA |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T104 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LtLVDtGIGMtKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T459 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEt |
| P08238 | T616 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVE |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09211 | T62 | Sugiyama | GSTP1 FAEES3 GST3 | GsLKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGK |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09211 | Y64 | Sugiyama | GSTP1 FAEES3 GST3 | LKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQ |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09429 | S15 | Sugiyama | HMGB1 HMG1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAs |
| P09429 | T22 | Sugiyama | HMGB1 HMG1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAsVNFsEFs |
| P09651 | S360 | Sugiyama | HNRNPA1 HNRPA1 | PyGGGGQyFAKPRNQGGyGGssssssyGsGRRF________ |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09651 | Y357 | Sugiyama | HNRNPA1 HNRPA1 | ssGPyGGGGQyFAKPRNQGGyGGssssssyGsGRRF_____ |
| P09651 | Y366 | Sugiyama | HNRNPA1 HNRPA1 | QyFAKPRNQGGyGGssssssyGsGRRF______________ |
| P09874 | T397 | Sugiyama | PARP1 ADPRT PPOL | PAAVNSsAsADKPLSNMKILtLGKLSRNKDEVKAMIEKLGG |
| P09972 | T123 | Sugiyama | ALDOC ALDC | IVVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGA |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | S83 | Sugiyama | HSPD1 HSP60 | IIEQsWGsPKVTKDGVtVAKsIDLKDKYKNIGAKLVQDVAN |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | T79 | Sugiyama | HSPD1 HSP60 | GRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKYKNIGAKLVQ |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T425 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | TAGGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEG |
| P11142 | T427 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGER |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | T319 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KNLDDGIDDERLRKEFsPFGtItsAKVMMEGGRSKGFGFVC |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | T147 | Sugiyama | IMPDH2 IMPD2 | VRDVFEAKARHGFCGIPITDtGRMGSRLVGIIssRDIDFLK |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P12814 | T424 | Sugiyama | ACTN1 | sIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEsDL |
| P12814 | T426 | Sugiyama | ACTN1 | HEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEsDLAA |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T34 | Sugiyama | EEF2 EF2 | DKKANIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEt |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | T582 | Sugiyama | EEF2 EF2 | EEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRL |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13796 | T174 | Sugiyama | LCP1 PLS2 | FNAVGDGIVLCKMINLSVPDtIDERTINKKKLTPFTIQENL |
| P13797 | T177 | Sugiyama | PLS3 | FKAVGDGIVLCKMINLSVPDtIDERAINKKKLTPFIIQENL |
| P13929 | T26 | Sugiyama | ENO3 | IFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGAstGIyEA |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T41 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtL |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S403 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | FKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDDFH |
| P14625 | S680 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDMLRR |
| P14868 | T327 | Sugiyama | DARS1 DARS PIG40 | ADTMVQIFKGLQERFQTEIQtVNKQFPCEPFKFLEPTLRLE |
| P15153 | T161 | Sugiyama | RAC2 | QGLALAKEIDSVKyLECsALtQRGLKtVFDEAIRAVLCPQP |
| P15170 | T315 | Sugiyama | GSPT1 ERF3A | NRSVDGPIRLPIVDKYKDMGtVVLGKLESGSICKGQQLVMM |
| P15259 | S189 | Sugiyama | PGAM2 PGAMM | EEIVPQIKAGKRVLIAAHGNsLRGIVKHLEGMSDQAIMELN |
| P15311 | S144 | Sugiyama | EZR VIL2 | LLGSYAVQAKFGDYNKEVHKsGyLSsERLIPQRVMDQHKLT |
| P15311 | S149 | Sugiyama | EZR VIL2 | AVQAKFGDYNKEVHKsGyLSsERLIPQRVMDQHKLTRDQWE |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15311 | Y146 | Sugiyama | EZR VIL2 | GSYAVQAKFGDYNKEVHKsGyLSsERLIPQRVMDQHKLTRD |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15531 | T103 | Sugiyama | NME1 NDPKA NM23 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T230 | Sugiyama | RPS2 RPS4 | PKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysy |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P15924 | S63 | Sugiyama | DSP | SRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQNCSDCLM |
| P16070 | T76 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | FNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRIHPNSI |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | T49 | Sugiyama | HSPA6 HSP70B' | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P17174 | S106 | Sugiyama | GOT1 | RLALGDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNG |
| P17174 | T110 | Sugiyama | GOT1 | GDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNGTNNK |
| P17844 | S520 | Sugiyama | DDX5 G17P1 HELR HLR1 | GKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAANY |
| P17844 | T440 | Sugiyama | DDX5 G17P1 HELR HLR1 | NSsEDyIHRIGRTARSTKtGtAytFFtPNNIKQVSDLISVL |
| P17844 | T443 | Sugiyama | DDX5 G17P1 HELR HLR1 | EDyIHRIGRTARSTKtGtAytFFtPNNIKQVSDLISVLREA |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18124 | S149 | Sugiyama | RPL7 | SINMLRIVEPYIAWGYPNLKsVNELIyKRGYGKINKKRIAL |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18124 | T170 | Sugiyama | RPL7 | VNELIyKRGYGKINKKRIALtDNALIARSLGKyGIICMEDL |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | S189 | Sugiyama | PGAM1 PGAMA CDABP0006 | EEIVPQIKEGKRVLIAAHGNsLRGIVKHLEGLSEEAIMELN |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S595 | Sugiyama | NCL | FVKGLsEDttEEtLKEsFDGsVRARIVTDRETGssKGFGFV |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P19338 | T587 | Sugiyama | NCL | RSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARIVTDRETG |
| P19338 | Y463 | Sugiyama | NCL | EKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsG |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22392 | T103 | Sugiyama | NME2 NM23B | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | S236 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GGNFGPGPGsNFRGGsDGyGsGRGFGDGyNGyGGGPGGGNF |
| P23193 | T256 | Sugiyama | TCEA1 GTF2S TFIIS | MRKNLTKEAIREHQMAKTGGtQTDLFtCGKCKKKNCTYTQV |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23396 | S104 | Sugiyama | RPS3 OK/SW-cl.26 | VELyAEKVAtRGLCAIAQAEsLRyKLLGGLAVRRACyGVLR |
| P23396 | T93 | Sugiyama | RPS3 OK/SW-cl.26 | VQKRFGFPEGsVELyAEKVAtRGLCAIAQAEsLRyKLLGGL |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23527 | S39 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P24752 | T220 | Sugiyama | ACAT1 ACAT MAT | TAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVtV |
| P25205 | T240 | Sugiyama | MCM3 | ILDDDLVDKAKPGDRVQVVGtYRCLPGKKGGYTSGTFRTVL |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P25789 | S7 | Sugiyama | PSMA4 HC9 PSC9 | ______________MSRRyDsRttIFsPEGRLYQVEYAMEA |
| P25789 | T9 | Sugiyama | PSMA4 HC9 PSC9 | ____________MSRRyDsRttIFsPEGRLYQVEYAMEAIG |
| P25789 | Y5 | Sugiyama | PSMA4 HC9 PSC9 | ________________MSRRyDsRttIFsPEGRLYQVEYAM |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26583 | S15 | Sugiyama | HMGB2 HMG2 | ______MGKGDPNKPRGKMssyAFFVQtCREEHKKKHPDss |
| P26583 | T22 | Sugiyama | HMGB2 HMG2 | GKGDPNKPRGKMssyAFFVQtCREEHKKKHPDssVNFAEFS |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27695 | S66 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | EDPPDQKtsPsGKPAtLKICsWNVDGLRAWIKKKGLDWVKE |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29401 | T454 | Sugiyama | TKT | LAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICFIRTsR |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P30043 | S202 | Sugiyama | BLVRB FLR SCAN | GHFMLRCLttDEyDGHstyPsHQyQ________________ |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | T101 | Sugiyama | PEBP1 PBP PEBP | YREWHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyV |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30086 | T44 | Sugiyama | PEBP1 PBP PEBP | PLHVTYAGAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLy |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30740 | S72 | Sugiyama | SERPINB1 ELANH2 MNEI PI2 | AQLSKTFHFNTVEEVHSRFQsLNADINKRGASYILKLANRL |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P31949 | T33 | Sugiyama | S100A11 MLN70 S100C | CIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKN |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P32969 | S135 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | RNFLGEKYIRRVRMRPGVACsVsQAQKDELILEGNDIELVS |
| P32969 | T186 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | TVKNKDIRKFLDGIyVsEKGtVQQADE______________ |
| P33121 | T695 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | KAKRPELRNYFRSQIDDLyStIKV_________________ |
| P33778 | S39 | Sugiyama | H2BC3 H2BFF HIST1H2BB | ITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKA |
| P33991 | T854 | Sugiyama | MCM4 CDC21 | AITKDMFEEALRALADDDFLtVtGKtVRLL___________ |
| P33991 | T856 | Sugiyama | MCM4 CDC21 | TKDMFEEALRALADDDFLtVtGKtVRLL_____________ |
| P33991 | T859 | Sugiyama | MCM4 CDC21 | MFEEALRALADDDFLtVtGKtVRLL________________ |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35269 | T41 | Sugiyama | GTF2F1 RAP74 | NTTKKyNIMAFNAADKVNFAtWNQARLERDLSNKKIyQEEE |
| P35579 | S1892 | Sugiyama | MYH9 | LKQLKRQLEEAEEEAQRANAsRRKLQRELEDAtEtADAMNR |
| P35579 | S1916 | Sugiyama | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T287 | Sugiyama | RPL4 RPL1 | WRKAAsLKsNyNLPMHKMINtDLsRILKsPEIQRALRAPRK |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36871 | S483 | Sugiyama | PGM1 | DKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDGSRIVFR |
| P37108 | T29 | Sugiyama | SRP14 | FLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVEGF |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37108 | Y27 | Sugiyama | SRP14 | EQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVE |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | T84 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | ELINALYPEGQAPVKKIQAstMAFKQMEQIsQFLQAAERYG |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | S93 | Sugiyama | RPS19 | GsMTKIYGGRQRNGVMPsHFsRGsKsVARRVLQALEGLKMV |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P41091 | T22 | Sugiyama | EIF2S3 EIF2G | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| P41091 | T41 | Sugiyama | EIF2S3 EIF2G | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| P41091 | T46 | Sugiyama | EIF2S3 EIF2G | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHt |
| P41091 | T9 | Sugiyama | EIF2S3 EIF2G | ____________MAGGEAGVtLGQPHLsRQDLttLDVtKLT |
| P41567 | T72 | Sugiyama | EIF1 SUI1 | DDyDKKKLVKAFKKKFACNGtVIEHPEyGEVIQLQGDQRKN |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42677 | T74 | Sugiyama | RPS27 MPS1 | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| P42766 | T64 | Sugiyama | RPL35 | LsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyKPLDLR |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S398 | Sugiyama | NAMPT PBEF PBEF1 | IAFGSGGGLLQKLTRDLLNCsFKCSYVVTNGLGINVFKDPV |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46776 | Y108 | Sugiyama | RPL27A | VNAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKAKF |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46778 | T124 | Sugiyama | RPL21 | sFLKRVKENDQKKKEAKEKGtWVQLKRQPAPPREAHFVRTN |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46940 | T1451 | Sugiyama | IQGAP1 KIAA0051 | DAKTPDKMKKsKsVKEDsNLtLQEKKEKIQTGLKKLTELGt |
| P46940 | T1471 | Sugiyama | IQGAP1 KIAA0051 | tLQEKKEKIQTGLKKLTELGtVDPKNKyQELINDIARDIRN |
| P46940 | T1509 | Sugiyama | IQGAP1 KIAA0051 | IRNQRRYRQRRKAELVKLQQtyAALNSKATFYGEQVDyyKS |
| P47756 | S184 | Sugiyama | CAPZB | TAHYKLTSTVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVs |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47756 | T186 | Sugiyama | CAPZB | HYKLTSTVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDC |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P48643 | S51 | Sugiyama | CCT5 CCTE KIAA0098 | LEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtVT |
| P48643 | T47 | Sugiyama | CCT5 CCTE KIAA0098 | RLMGLEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGD |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | T49 | Sugiyama | HSPA7 HSP70B | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P49207 | T35 | Sugiyama | RPL34 | tASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLRG |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49368 | T373 | Sugiyama | CCT3 CCTG TRIC5 | KKIGDEYFTFITDCKDPKACtILLRGAsKEILSEVERNLQD |
| P49368 | T430 | Sugiyama | CCT3 CCTG TRIC5 | GGGASEMAVAHALTEKSKAMtGVEQWPyRAVAQALEVIPRT |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P49589 | S34 | Sugiyama | CARS1 CARS | VQPQWsPPAGtQPCRLHLyNsLtRNKEVFIPQDGKKVTWYC |
| P50395 | T205 | Sugiyama | GDI2 RABGDIB | TGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsPYL |
| P50454 | S138 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEH |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50914 | T43 | Sugiyama | RPL14 | KLVAIVDVIDQNRALVDGPCtQVRRQAMPFKCMQLTDFILK |
| P50990 | T374 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EVGDTQVVVFKHEKEDGAIstIVLRGstDNLMDDIERAVDD |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T610 | Sugiyama | FXR2 FMR1L2 | RRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLER |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P51991 | S370 | Sugiyama | HNRNPA3 HNRPA3 | sFGGRssGsPyGGGyGsGGGsGGyGsRRF____________ |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P53621 | T821 | Sugiyama | COPA | IMPLDTNWPLLTVSKGFFEGtIAsKGKGGALAADIDIDTVG |
| P53999 | S56 | Sugiyama | SUB1 PC4 RPO2TC1 | PVKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRD |
| P54105 | T36 | Sugiyama | CLNS1A CLCI ICLN | LLRQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSL |
| P54646 | T172 | PSP | PRKAA2 AMPK AMPK2 | NAKIADFGLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55209 | T269 | Sugiyama | NAP1L1 NRP | GPEIMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVT |
| P55209 | T272 | Sugiyama | NAP1L1 NRP | IMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVTKTV |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P56192 | S812 | Sugiyama | MARS1 MARS | GHQIGTVSPLFQKLENDQIEsLRQRFGGGQAKtsPKPAVVE |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P57059 | T182 | PSP | SIK1 SIK SNF1LK | DIKLADFGFGNFYKSGEPLStWCGsPPYAAPEVFEGKEYEG |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S21 | Sugiyama | TPI1 TPI | MAPSRKFFVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T28 | Sugiyama | TPI1 TPI | FVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVVCAPPtAy |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60763 | T161 | Sugiyama | RAC3 | QGLAMAREIGSVKyLECsALtQRGLKtVFDEAIRAVLCPPP |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P60866 | T6 | Sugiyama | RPS20 | _______________MAFKDtGKtPVEPEVAIHRIRITLTS |
| P61006 | T72 | SIGNOR|PSP | RAB8A MEL RAB8 | LDGKRIKLQIWDtAGQERFRtITTAYYRGAMGIMLVYDITN |
| P61221 | T183 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | DLKAIIKPQYVDQIPKAAKGtVGsILDRKDETKTQAIVCQQ |
| P61247 | S192 | Sugiyama | RPS3A FTE1 MFTL | MTREVQTNDLKEVVNKLIPDsIGKDIEKACQsIyPLHDVFV |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61254 | S23 | Sugiyama | RPL26 | FNPFVtsDRsKNRKRHFNAPsHIRRKIMssPLSKELRQKYN |
| P61254 | S31 | Sugiyama | RPL26 | RsKNRKRHFNAPsHIRRKIMssPLSKELRQKYNVRSMPIRK |
| P61254 | T93 | Sugiyama | RPL26 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| P61254 | T94 | Sugiyama | RPL26 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61353 | T94 | Sugiyama | RPL27 | VyNyNHLMPtRysVDIPLDKtVVNKDVFRDPALKRKARREA |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | T16 | Sugiyama | RPL37A | _____MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAK |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61927 | S50 | Sugiyama | RPL37 | QKSTCGKCGYPAKRKRKYNWsAKAKRRNTTGTGRMRHLKIV |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62241 | S115 | Sugiyama | RPS8 OK/SW-cl.83 | TLVKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEE |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | T69 | Sugiyama | RPS18 D6S218E | DIDLTKRAGELtEDEVERVItIMQNPRQYKIPDWFLNRQKD |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | S67 | Sugiyama | RPS11 | PKEAIEGtyIDKKCPFTGNVsIRGRILsGVVTKMKMQRTIV |
| P62280 | T127 | Sugiyama | RPS11 | KNMsVHLsPCFRDVQIGDIVtVGECRPLsKTVRFNVLKVTK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62312 | T75 | Sugiyama | LSM6 | QLKNKyGDAFIRGNNVLyIstQKRRM_______________ |
| P62314 | T57 | Sugiyama | SNRPD1 | NTHLKAVKMTLKNREPVQLEtLsIRGNNIRYFILPDsLPLD |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T142 | Sugiyama | RPL7A SURF-3 SURF3 | AAGKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVD |
| P62424 | T144 | Sugiyama | RPL7A SURF-3 SURF3 | GKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPI |
| P62424 | T145 | Sugiyama | RPL7A SURF-3 SURF3 | KGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPIE |
| P62424 | T201 | Sugiyama | RPL7A SURF-3 SURF3 | YCIIKGKARLGRLVHRKTCTtVAFTQVNsEDKGALAKLVEA |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62701 | T159 | Sugiyama | RPS4X CCG2 RPS4 SCAR | LVtHDARTIRYPDPLIKVNDtIQIDLEtGKITDFIKFDtGN |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62753 | S53 | Sugiyama | RPS6 OK/SW-cl.2 | AtEVAADALGEEWKGYVVRIsGGNDKQGFPMKQGVLTHGRV |
| P62753 | T127 | Sugiyama | RPS6 OK/SW-cl.2 | SVLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNL |
| P62753 | T128 | Sugiyama | RPS6 OK/SW-cl.2 | VLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNLs |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62829 | S41 | Sugiyama | RPL23 | PVGAVINCADNTGAKNLyIIsVKGIKGRLNRLPAAGVGDMV |
| P62847 | S78 | Sugiyama | RPS24 | FGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYE |
| P62847 | T70 | Sugiyama | RPS24 | TTPDVIFVFGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHR |
| P62851 | S74 | Sugiyama | RPS25 | tyDKLCKEVPNYKLItPAVVsERLKIRGSLARAALQELLsK |
| P62888 | T83 | Sugiyama | RPL30 | yAMLAKtGVHHysGNNIELGtACGKyyRVCtLAIIDPGDsD |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62913 | S59 | Sugiyama | RPL11 | VLEQLtGQtPVFsKARyTVRsFGIRRNEKIAVHCTVRGAKA |
| P62913 | Y55 | Sugiyama | RPL11 | RAAKVLEQLtGQtPVFsKARyTVRsFGIRRNEKIAVHCTVR |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63000 | T161 | Sugiyama | RAC1 TC25 MIG5 | QGLAMAKEIGAVKyLECsALtQRGLKtVFDEAIRAVLCPPP |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63165 | S61 | Sugiyama | SUMO1 SMT3C SMT3H3 UBL1 OK/SW-cl.43 | TTHLKKLKESYCQRQGVPMNsLRFLFEGQRIADNHtPKELG |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63173 | T44 | Sugiyama | RPL38 | KIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPGL |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T89 | Sugiyama | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T22 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68400 | T127 | Sugiyama | CSNK2A1 CK2A1 | RTPALVFEHVNNTDFKQLyQtLTDYDIRFYMYEILKALDYC |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P83731 | Y55 | Sugiyama | RPL24 | KCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRTRRA |
| P84098 | S122 | Sugiyama | RPL19 | LRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P99999 | T50 | Sugiyama | CYCS CYC | GPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEYLE |
| Q00341 | T729 | Sugiyama | HDLBP HBP VGL | VEKAKKQLLHLAEEKQTKSFtVDIRAKPEYHKFLIGKGGGK |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q00839 | T554 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | MDKMMVAGFKKQMADtGKLNtLLQRAPQCLGKFIEIAARKK |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T102 | Sugiyama | RPL18A | LRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAH |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q02878 | S198 | Sugiyama | RPL6 TXREB1 | PLVLNRVPLRRTHQKFVIAtsTKIDISNVKIPKHLtDAyFK |
| Q02878 | S255 | Sugiyama | RPL6 TXREB1 | tEKEKYEITEQRKIDQKAVDsQILPKIKAIPQLQGYLRSVF |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | T197 | Sugiyama | RPL6 TXREB1 | GPLVLNRVPLRRTHQKFVIAtsTKIDISNVKIPKHLtDAyF |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q02878 | T91 | Sugiyama | RPL6 TXREB1 | RKYSAAKSKVEKKKKEKVLAtVtKPVGGDKNGGTRVVKLRK |
| Q04637 | T1119 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GGSGAKPSDAAsEAARPAtstLNRFsALQQAVPtEsTDNRR |
| Q04760 | T35 | Sugiyama | GLO1 | AALSCCSDADPSTKDFLLQQtMLRVKDPKKSLDFyTRVLGM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T22 | Sugiyama | EEF1A2 EEF1AL STN | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | S30 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | HPAPNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTF |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q06830 | T18 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | ___MSSGNAKIGHPAPNFKAtAVMPDGQFKDIsLsDyKGKY |
| Q07020 | S140 | Sugiyama | RPL18 | ILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAPGtPH |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T39 | Sugiyama | RPL18 | KSQDIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRP |
| Q07020 | T42 | Sugiyama | RPL18 | DIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPLs |
| Q07020 | T79 | Sugiyama | RPL18 | PPLsLsRMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLK |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q12965 | T945 | Sugiyama | MYO1E MYO1C | PKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGyHQNG |
| Q13011 | T208 | Sugiyama | ECH1 | AQDAFFQVKEVDVGLAADVGtLQRLPKVIGNQSLVNELAFT |
| Q13131 | T183 | PSP | PRKAA1 AMPK1 | NAKIADFGLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| Q13136 | T572 | Sugiyama | PPFIA1 LIP1 | LRRPQKGRLAALRDEPSKVQtLNEQDWERAQQASVLANVAQ |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S253 | Sugiyama | G3BP1 G3BP | PAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPH |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13765 | T119 | Sugiyama | NACA HSD48 | SKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAA |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14151 | S613 | Sugiyama | SAFB2 KIAA0138 | ERSSKSQDRKSESKEKRDILsFDKIKEQRERERQRQREREI |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14157 | S356 | Sugiyama | UBAP2L KIAA0144 NICE4 | HsMVsMLGKGFGDVGEAKGGsttGsQFLEQFKTAQALAQLA |
| Q14157 | T357 | Sugiyama | UBAP2L KIAA0144 NICE4 | sMVsMLGKGFGDVGEAKGGsttGsQFLEQFKTAQALAQLAA |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14247 | S117 | Sugiyama | CTTN EMS1 | KsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVDQsAV |
| Q14320 | T64 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | NIDKKFsAHyDAVEAELKsstVGLVtLNDMKAKQEALVKER |
| Q14320 | T69 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | FsAHyDAVEAELKsstVGLVtLNDMKAKQEALVKEREKQLA |
| Q14498 | T175 | Sugiyama | RBM39 HCC1 RNPC2 | VFCMQLAARIRPRDLEEFFStVGKVRDVRMISDRNSRRSKG |
| Q14498 | T353 | Sugiyama | RBM39 HCC1 RNPC2 | ssAssFLDsDELERtGIDLGtTGRLQLMARLAEGTGLQIPP |
| Q14568 | T109 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LTIVDTGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14697 | T40 | Sugiyama | GANAB G2AN KIAA0088 | LAFLGVCLGITLAVDRSNFKtCEEssFCKRQRsIRPGLsPy |
| Q14974 | T863 | Sugiyama | KPNB1 NTF97 | IHELLTEGRRSKTNKAKtLAtWATKELRKLKNQA_______ |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15021 | S1310 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | RACHTRGLDGIKELEIGQAGsQRAPsAKKPSTGSRyQPLAs |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15084 | S169 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFYAPW |
| Q15084 | S230 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | QTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPV |
| Q15084 | T223 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AAsEVKEQTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIF |
| Q15084 | T239 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPVDyDGGRTRs |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15208 | T444 | GPS6|SIGNOR|EPSD | STK38 NDR1 | ATSNHPETDYKNKDWVFINytYKRFEGLtARGAIPsYMKAA |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | T163 | Sugiyama | RCN1 RCN | AtyGyyLGNPAEFHDssDHHtFKKMLPRDERRFKAADLNGD |
| Q15560 | T254 | Sugiyama | TCEA2 | IRKAMTKEAIREHQMARTGGtQTDLFtCGKCRKKNCTYTQV |
| Q16181 | T318 | Sugiyama | SEPTIN7 CDC10 SEPT7 | KDVTNNVHyENyRSRKLAAVtyNGVDNNKNKGQLtKsPLAQ |
| Q16181 | T426 | Sugiyama | SEPTIN7 CDC10 SEPT7 | DEKANWEAQQRILEQQNssRtLEKNKKKGKIF_________ |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q16778 | S39 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKA |
| Q27J81 | S1202 | Sugiyama | INF2 C14orf151 C14orf173 | EsALDtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRR |
| Q27J81 | S1204 | Sugiyama | INF2 C14orf151 C14orf173 | ALDtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKK |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q2VIR3 | T22 | Sugiyama | EIF2S3B | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| Q2VIR3 | T41 | Sugiyama | EIF2S3B | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| Q2VIR3 | T46 | Sugiyama | EIF2S3B | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHT |
| Q2VIR3 | T9 | Sugiyama | EIF2S3B | ____________MAGGEAGVtLGQPHLsRQDLttLDVtKLT |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q53EL6 | S49 | Sugiyama | PDCD4 H731 | ENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNssR |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | S60 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | FKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDDFR |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | T489 | Sugiyama | HSP90AB3P HSP90BC | YGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIME |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | T104 | Sugiyama | HSP90AB2P HSP90BB | LTLVDTGIGMTKADLINNLGtIAKFQDQTEYLEEMQVKEVV |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5VTE0 | T22 | Sugiyama | EEF1A1P5 EEF1AL3 | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6DN03 | S39 | Sugiyama | H2BC20P HIST2H2BC | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6DRA6 | S39 | Sugiyama | H2BC19P HIST2H2BD | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q71UM5 | T74 | Sugiyama | RPS27L | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| Q7KZF4 | S126 | Sugiyama | SND1 TDRD11 | GREyGMIyLGKDTNGENIAEsLVAEGLAtRREGMRANNPEQ |
| Q7KZF4 | T134 | Sugiyama | SND1 TDRD11 | LGKDTNGENIAEsLVAEGLAtRREGMRANNPEQNRLsECEE |
| Q7L7X3 | T440 | PSP | TAOK1 KIAA1361 MAP3K16 MARKK | QsPPQVSRHKSHYRNREHFAtIRtAsLVTRQMQEHEQDSEL |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UE4 | T477 | Sugiyama | MTDH AEG1 LYRIC | stAQDtEELEKEIREDLPVNtsKTRPKQEKAFSLKtIstsD |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IYD1 | T444 | Sugiyama | GSPT2 ERF3B | NRSIDGPIRLPIVDKYKDMGtVVLGKLESGSIFKGQQLVMM |
| Q8N257 | S39 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | VTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKA |
| Q8N6T3 | T292 | Sugiyama | ARFGAP1 ARF1GAP | VsQLAsKVQGVGSKGWRDVttFFsGKAEGPLDsPSEGHSyQ |
| Q8TAE6 | T73 | EPSD|PSP | PPP1R14C KEPI | AAAAGQVQQQQQRRHQQGKVtVKYDRKELRKRLVLEEWIVE |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q8WU90 | T348 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | sVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLs |
| Q8WVK2 | S123 | Sugiyama | SNRNP27 | MMKLMGFASFDSTKGKKVDGsVNAyAINVsQKRKYRQYMNR |
| Q8WVK2 | S132 | Sugiyama | SNRNP27 | FDSTKGKKVDGsVNAyAINVsQKRKYRQYMNRKGGFNRPLD |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92522 | T55 | Sugiyama | H1-10 H1FX | KRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLAKIYTEAK |
| Q92522 | Y48 | Sugiyama | H1-10 H1FX | AALsPsKKRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLA |
| Q92688 | T105 | Sugiyama | ANP32B APRIL PHAPI2 | EKLPNLTHLNLsGNKLKDIstLEPLKKLECLKsLDLFNCEV |
| Q92882 | T200 | Sugiyama | OSTF1 | ATNAACAsLLKKKQGTDAVRtLsNAEDyLDDEDsD______ |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96AY3 | T200 | Sugiyama | FKBP10 FKBP65 PSEC0056 | HYNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLG |
| Q96AY3 | T203 | Sugiyama | FKBP10 FKBP65 PSEC0056 | GTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCP |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q99497 | T154 | Sugiyama | PARK7 | MNGGHytysENRVEKDGLILtSRGPGTSFEFALAIVEALNG |
| Q99575 | S126 | Sugiyama | POP1 KIAA0061 | tFAQARAAEISAMLKAVTQKssNsLVFQtLPRHMRRRAMSH |
| Q99575 | S127 | Sugiyama | POP1 KIAA0061 | FAQARAAEISAMLKAVTQKssNsLVFQtLPRHMRRRAMSHN |
| Q99575 | T103 | Sugiyama | POP1 KIAA0061 | KKGGWKAGPEGTsQEIPKyItAStFAQARAAEISAMLKAVT |
| Q99575 | T106 | Sugiyama | POP1 KIAA0061 | GWKAGPEGTsQEIPKyItAStFAQARAAEISAMLKAVTQKs |
| Q99575 | T134 | Sugiyama | POP1 KIAA0061 | EISAMLKAVTQKssNsLVFQtLPRHMRRRAMSHNVKRLPRR |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99733 | T58 | Sugiyama | NAP1L4 NAP2 | LAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQVRCA |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q99832 | T371 | Sugiyama | CCT7 CCTH NIP7-1 | tQIGGERyNFFtGCPKAKTCtFILRGGAEQFMEEtERSLHD |
| Q99832 | T57 | Sugiyama | CCT7 CCTH NIP7-1 | RTTLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAK |
| Q99832 | T64 | Sugiyama | CCT7 CCTH NIP7-1 | GMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTLVDIAK |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BS26 | T155 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | yIRQQKSDPIQEIRDLAEIttLDRSKRNIIGYFEQKDSDNy |
| Q9BUJ2 | S512 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | IQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIVIC |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9H0B6 | T447 | Sugiyama | KLC2 | DsAPyGEyGsWYKACKVDsPtVNTTLRSLGALYRRQGKLEA |
| Q9H0K1 | T175 | PSP | SIK2 KIAA0781 QIK SNF1LK2 | NIKIADFGFGNFFKSGELLAtWCGSPPYAAPEVFEGQQYEG |
| Q9H2U1 | T179 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | NRsyIDRDsEyLLQENEPDGtLDQKLLEDLQKKKNDLRYIE |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9H814 | T151 | Sugiyama | PHAX RNUXA | ATELGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDL |
| Q9HB07 | T192 | Sugiyama | MYG1 C12orf10 | VDAVDNGISQWAEGEPRyALttTLsARVARLNPTWNHPDQD |
| Q9HB07 | T193 | Sugiyama | MYG1 C12orf10 | DAVDNGISQWAEGEPRyALttTLsARVARLNPTWNHPDQDT |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NRG1 | S169 | Sugiyama | PRTFDC1 HHGP | TMKALLSNIEKYKPNMIKVAsLLVKRTSRSDGFRPDYAGFE |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NZZ3 | T23 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | RLFGKAKPKAPPPsLtDCIGtVDsRAEsIDKKISRLDAELV |
| Q9P0J1 | T494 | Sugiyama | PDP1 PDP PPM2C | EDQNAATHLIRHAVGNNEFGtVDHERLSKMLSLPEELARMY |
| Q9P258 | T20 | Sugiyama | RCC2 KIAA1470 TD60 | _MPRKKAAAAAWEEPssGNGtARAGPRKRGGPAGRKRERPE |
| Q9UBR2 | S195 | Sugiyama | CTSZ | EFKECHAIRNYTLWRVGDYGsLSGREKMMAEIYANGPISCG |
| Q9UBT2 | T174 | Sugiyama | UBA2 SAE2 UBLE1B HRIHFB2115 | GVtECyECHPKPTQRTFPGCtIRNTPSEPIHCIVWAKYLFN |
| Q9UHA3 | T64 | Sugiyama | RSL24D1 C15orf15 RPL24L My024 | RNPRKVRWTKAFRKAAGKELtVDNsFEFEKRRNEPIKYQRE |
| Q9UHD1 | T204 | Sugiyama | CHORDC1 CHP1 | IFHEGMKYWSCCRRKtsDFNtFLAQEGCtKGKHMWTKKDAG |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UJW0 | T141 | Sugiyama | DCTN4 | VGMADKSVASGGWQEPENPHtQRMNKLIEyyQQLAQKEKVE |
| Q9ULW6 | T342 | Sugiyama | NAP1L2 BPX | GTAIEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVT |
| Q9ULW6 | T345 | Sugiyama | NAP1L2 BPX | IEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVTEDF |
| Q9UNX3 | S31 | Sugiyama | RPL26L1 RPL26P1 | RsKNRKRHFNAPSHVRRKIMssPLSKELRQKYNVRSMPIRK |
| Q9UNX3 | T93 | Sugiyama | RPL26L1 RPL26P1 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| Q9UNX3 | T94 | Sugiyama | RPL26L1 RPL26P1 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9Y247 | T64 | Sugiyama | FAM50B X5L | QVDKRFSAHyDAVEAELKsstVGLVtLNDMKARQEALVRER |
| Q9Y247 | T69 | Sugiyama | FAM50B X5L | FSAHyDAVEAELKsstVGLVtLNDMKARQEALVRERERQLA |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T100 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ELLEEICDRMKEyGEQIDPstHRKNYVRVVGRNGEssELDL |
| Q9Y2B0 | T132 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDELIEFF |
| Q9Y2H1 | T442 | GPS6|SIGNOR|ELM|EPSD|PSP | STK38L KIAA0965 NDR2 | PVPNTTEPDYKSKDWVFLNytYKRFEGLtQRGsIPTYMKAG |
| Q9Y2K2 | T221 | PSP | SIK3 KIAA0999 QSK L19 | NIKIADFGFSNLFTPGQLLKtWCGSPPYAAPELFEGKEYDG |
| Q9Y2W1 | S232 | Sugiyama | THRAP3 BCLAF2 TRAP150 | QDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPALK |
| Q9Y2W1 | T227 | Sugiyama | THRAP3 BCLAF2 TRAP150 | sGGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRER |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y3A5 | T113 | Sugiyama | SBDS CGI-97 | VQVSDKERHTQLEQMFRDIAtIVADKCVNPETKRPYtVILI |
| Q9Y3F4 | T66 | Sugiyama | STRAP MAWD UNRIP | GDtGDWIGtFLGHKGAVWGAtLNKDATKAATAAADFTAKVW |
| Q9Y3S2 | S25 | Sugiyama | ZNF330 NOA36 | KTGARKKAENRREREKQLRAsRstIDLAKHPCNASMECDKC |
| Q9Y3S2 | T28 | Sugiyama | ZNF330 NOA36 | ARKKAENRREREKQLRAsRstIDLAKHPCNASMECDKCQRR |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5L4 | T79 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | DNSEQKCIAMCMDRyMDAWNtVsRAYNSRLQRERANM____ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y6E0 | S357 | Sugiyama | STK24 MST3 STK3 | WIFTIREKDPKNLENGALQPsDLDRNKMKDIPKRPFSQCLS |
| Q9Y6E0 | S391 | Sugiyama | STK24 MST3 STK3 | PFSQCLSTIISPLFAELKEKsQACGGNLGsIEELRGAIYLA |
| Q9Y6E0 | S400 | Sugiyama | STK24 MST3 STK3 | ISPLFAELKEKsQACGGNLGsIEELRGAIYLAEEACPGISD |
| Q9Y6E0 | S434 | Sugiyama | STK24 MST3 STK3 | ACPGISDTMVAQLVQRLQRYsLSGGGtSsH___________ |
| Q9Y6E0 | T182 | Sugiyama | STK24 MST3 STK3 | VLLSEHGEVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEV |
| Q9Y6E0 | T184 | Sugiyama | STK24 MST3 STK3 | LSEHGEVKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEVIK |
| Q9Y6E0 | T190 | GPS6|SIGNOR|EPSD|PSP | STK24 MST3 STK3 | VKLADFGVAGQLtDtQIKRNtFVGTPFWMAPEVIKQSAYDS |
| Q9Y6E0 | T440 | Sugiyama | STK24 MST3 STK3 | DTMVAQLVQRLQRYsLSGGGtSsH_________________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.771561e-16 | 15.109 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.771561e-16 | 15.109 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.998401e-15 | 14.699 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.218847e-15 | 14.375 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.440892e-15 | 14.353 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.881784e-15 | 14.051 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.310063e-14 | 13.883 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.231548e-14 | 13.651 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.475797e-14 | 13.606 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.485301e-14 | 13.348 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.629630e-14 | 13.334 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.684342e-14 | 13.245 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.683543e-14 | 13.175 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.693046e-14 | 13.061 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.623146e-13 | 12.790 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.955103e-13 | 12.709 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.089440e-13 | 12.680 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.654543e-13 | 12.576 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.843592e-13 | 12.415 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.290524e-13 | 12.201 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.212808e-13 | 12.207 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.590595e-13 | 12.120 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.123502e-13 | 12.090 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.280198e-12 | 11.893 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.287748e-12 | 11.890 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.379119e-12 | 11.860 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.829981e-12 | 11.738 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.743894e-12 | 11.427 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.949507e-12 | 11.403 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.256484e-12 | 11.371 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.761946e-12 | 11.239 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.130496e-11 | 10.947 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.477996e-11 | 10.830 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.004141e-11 | 10.698 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.605294e-11 | 10.443 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.054246e-11 | 10.392 | 1 | 1 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.273282e-11 | 10.369 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.806111e-11 | 10.318 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.862189e-11 | 10.006 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.049532e-10 | 9.979 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.471675e-10 | 9.832 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.993787e-10 | 9.700 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.048930e-10 | 9.516 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.462161e-10 | 9.461 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.682815e-10 | 9.329 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.927296e-10 | 9.227 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.082985e-10 | 9.150 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.082985e-10 | 9.150 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.789000e-10 | 9.009 | 1 | 1 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.066512e-09 | 8.972 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.671700e-09 | 8.777 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.671700e-09 | 8.777 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.658617e-09 | 8.780 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.745119e-09 | 8.758 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.254135e-09 | 8.647 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.254135e-09 | 8.647 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.254135e-09 | 8.647 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.742096e-09 | 8.562 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.771535e-09 | 8.557 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.914582e-09 | 8.535 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.736174e-09 | 8.428 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.837078e-09 | 8.416 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.279973e-09 | 8.369 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.012762e-09 | 8.300 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.957218e-09 | 8.158 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.177753e-09 | 8.087 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.405122e-09 | 8.075 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.096179e-09 | 8.041 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.096179e-09 | 8.041 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.111080e-08 | 7.954 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.167401e-08 | 7.933 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.522419e-08 | 7.817 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.619852e-08 | 7.791 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.148167e-08 | 7.668 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.152210e-08 | 7.667 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.371105e-08 | 7.625 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.655167e-08 | 7.576 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.692466e-08 | 7.570 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.301289e-08 | 7.481 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.364702e-08 | 7.473 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.395630e-08 | 7.469 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.990762e-08 | 7.399 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.503191e-08 | 7.346 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.522700e-08 | 7.186 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.150965e-08 | 7.146 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.979739e-08 | 7.047 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.979739e-08 | 7.047 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.034101e-07 | 6.985 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.283418e-07 | 6.892 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.821895e-07 | 6.739 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.239478e-07 | 6.650 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.956268e-07 | 6.529 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.040758e-07 | 6.517 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.122755e-07 | 6.505 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.004378e-07 | 6.397 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.371052e-07 | 6.359 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.640301e-07 | 6.249 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.824894e-07 | 6.235 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.920263e-07 | 6.101 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.176587e-06 | 5.662 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.315751e-06 | 5.635 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.438079e-06 | 5.613 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.165542e-06 | 5.500 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.739498e-06 | 5.427 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.748974e-06 | 5.426 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.833171e-06 | 5.416 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.542080e-06 | 5.343 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.294032e-06 | 5.201 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.630343e-06 | 5.178 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.915530e-06 | 5.102 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.022213e-05 | 4.990 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.132037e-05 | 4.946 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.191279e-05 | 4.924 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.196878e-05 | 4.922 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.564925e-05 | 4.806 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.904102e-05 | 4.720 | 1 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.020303e-05 | 4.695 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.500053e-05 | 4.602 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.675168e-05 | 4.573 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.115672e-05 | 4.506 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.277448e-05 | 4.484 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.032972e-05 | 4.518 | 1 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.127550e-05 | 4.505 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.288714e-05 | 4.483 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.452759e-05 | 4.462 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.507666e-05 | 4.455 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.055090e-05 | 4.392 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.187628e-05 | 4.378 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.634099e-05 | 4.334 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.629581e-05 | 4.250 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.342301e-05 | 4.134 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.370068e-05 | 4.077 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.549278e-05 | 4.020 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.763993e-05 | 4.010 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.060670e-04 | 3.974 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.112761e-04 | 3.954 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.132834e-04 | 3.946 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.155472e-04 | 3.937 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.357987e-04 | 3.867 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.458142e-04 | 3.836 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.528922e-04 | 3.816 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.528922e-04 | 3.816 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.701388e-04 | 3.769 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.978169e-04 | 3.704 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.982920e-04 | 3.703 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.148237e-04 | 3.668 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.148237e-04 | 3.668 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.602777e-04 | 3.585 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.702159e-04 | 3.568 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.705054e-04 | 3.568 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.900010e-04 | 3.538 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.191947e-04 | 3.496 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.555156e-04 | 3.449 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.558874e-04 | 3.449 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.806606e-04 | 3.419 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.379238e-04 | 3.359 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.580549e-04 | 3.339 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.651639e-04 | 3.332 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.928588e-04 | 3.307 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.590617e-04 | 3.253 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.695935e-04 | 3.174 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.572226e-04 | 3.121 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.688514e-04 | 3.114 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.242016e-04 | 3.084 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.310521e-04 | 3.080 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.340322e-04 | 3.079 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.120333e-04 | 3.040 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.650789e-04 | 3.015 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.008627e-03 | 2.996 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.009288e-03 | 2.996 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.184133e-03 | 2.927 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.345156e-03 | 2.871 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.371124e-03 | 2.863 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.388422e-03 | 2.857 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.438221e-03 | 2.842 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.453757e-03 | 2.838 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.453757e-03 | 2.838 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.574927e-03 | 2.803 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.919258e-03 | 2.717 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.979049e-03 | 2.704 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.991164e-03 | 2.701 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.189149e-03 | 2.660 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.163007e-03 | 2.665 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.189149e-03 | 2.660 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.089736e-03 | 2.680 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.302560e-03 | 2.638 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.302560e-03 | 2.638 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.509817e-03 | 2.600 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.518392e-03 | 2.599 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.600656e-03 | 2.585 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.613009e-03 | 2.583 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.613009e-03 | 2.583 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.724095e-03 | 2.565 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.841313e-03 | 2.546 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.488077e-03 | 2.457 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.559882e-03 | 2.449 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.559882e-03 | 2.449 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.814663e-03 | 2.419 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.824820e-03 | 2.417 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.020190e-03 | 2.396 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.043597e-03 | 2.393 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.190450e-03 | 2.378 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.858518e-03 | 2.313 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.389141e-03 | 2.268 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.190009e-03 | 2.208 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.927271e-03 | 2.227 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.534361e-03 | 2.257 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.389141e-03 | 2.268 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.601693e-03 | 2.252 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.115505e-03 | 2.214 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.401003e-03 | 2.194 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.002372e-03 | 2.155 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.002372e-03 | 2.155 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 7.002372e-03 | 2.155 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 7.002372e-03 | 2.155 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.002372e-03 | 2.155 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.369203e-03 | 2.133 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.401154e-03 | 2.131 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.765695e-03 | 2.110 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.038735e-03 | 2.095 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.179742e-03 | 2.087 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.270136e-03 | 2.082 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.744288e-03 | 2.058 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 9.346222e-03 | 2.029 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 9.346222e-03 | 2.029 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.507663e-03 | 2.022 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.017013e-02 | 1.993 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.030364e-02 | 1.987 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.030364e-02 | 1.987 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.124256e-02 | 1.949 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.134565e-02 | 1.945 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.155218e-02 | 1.937 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 1.155218e-02 | 1.937 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.205530e-02 | 1.919 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.205530e-02 | 1.919 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.272545e-02 | 1.895 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.279557e-02 | 1.893 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.331232e-02 | 1.876 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.610264e-02 | 1.793 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.610264e-02 | 1.793 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.610264e-02 | 1.793 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.610264e-02 | 1.793 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.610264e-02 | 1.793 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.610264e-02 | 1.793 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.610264e-02 | 1.793 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.610264e-02 | 1.793 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.610264e-02 | 1.793 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.610264e-02 | 1.793 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.610264e-02 | 1.793 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.610264e-02 | 1.793 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.610264e-02 | 1.793 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.610264e-02 | 1.793 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.610264e-02 | 1.793 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.349406e-02 | 1.870 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.382194e-02 | 1.859 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.445784e-02 | 1.840 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.573589e-02 | 1.803 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.635630e-02 | 1.786 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.755171e-02 | 1.756 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.807374e-02 | 1.743 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.852198e-02 | 1.732 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.852198e-02 | 1.732 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.852198e-02 | 1.732 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.895189e-02 | 1.722 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.906162e-02 | 1.720 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.957295e-02 | 1.708 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.961824e-02 | 1.707 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.963941e-02 | 1.707 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.979438e-02 | 1.703 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.988691e-02 | 1.701 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.990947e-02 | 1.701 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.055749e-02 | 1.687 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.216531e-02 | 1.654 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.225190e-02 | 1.653 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.235521e-02 | 1.651 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.279241e-02 | 1.642 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.438688e-02 | 1.613 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 2.524747e-02 | 1.598 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.562647e-02 | 1.591 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.562647e-02 | 1.591 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.469996e-02 | 1.607 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.703135e-02 | 1.568 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.929235e-02 | 1.533 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.950393e-02 | 1.530 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.524747e-02 | 1.598 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.562647e-02 | 1.591 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.438688e-02 | 1.613 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.950393e-02 | 1.530 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.498776e-02 | 1.602 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.703135e-02 | 1.568 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.784220e-02 | 1.555 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.606520e-02 | 1.584 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.716704e-02 | 1.566 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.046306e-02 | 1.516 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.191303e-02 | 1.496 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.191303e-02 | 1.496 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.340608e-02 | 1.476 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.340608e-02 | 1.476 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.404190e-02 | 1.468 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.404190e-02 | 1.468 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.404190e-02 | 1.468 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 3.404190e-02 | 1.468 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 3.404190e-02 | 1.468 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.404190e-02 | 1.468 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.573715e-02 | 1.447 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.619973e-02 | 1.441 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.619973e-02 | 1.441 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.632773e-02 | 1.440 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.632773e-02 | 1.440 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.751107e-02 | 1.426 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.751107e-02 | 1.426 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.875345e-02 | 1.412 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.108153e-02 | 1.386 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.169657e-02 | 1.380 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.177635e-02 | 1.379 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.206748e-02 | 1.376 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.206748e-02 | 1.376 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.244967e-02 | 1.372 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.244967e-02 | 1.372 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.244967e-02 | 1.372 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.244967e-02 | 1.372 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.244967e-02 | 1.372 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.244967e-02 | 1.372 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.244967e-02 | 1.372 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.244967e-02 | 1.372 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.244967e-02 | 1.372 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 4.669336e-02 | 1.331 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 4.669336e-02 | 1.331 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 4.669336e-02 | 1.331 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 4.669336e-02 | 1.331 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 4.669336e-02 | 1.331 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 4.669336e-02 | 1.331 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 4.669336e-02 | 1.331 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 4.669336e-02 | 1.331 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 4.669336e-02 | 1.331 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 4.669336e-02 | 1.331 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 4.669336e-02 | 1.331 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 4.669336e-02 | 1.331 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 4.669336e-02 | 1.331 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.669336e-02 | 1.331 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.669336e-02 | 1.331 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.492198e-02 | 1.348 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.920224e-02 | 1.308 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.692243e-02 | 1.329 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.207501e-02 | 1.283 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.744005e-02 | 1.324 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.744005e-02 | 1.324 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.744005e-02 | 1.324 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.096340e-02 | 1.293 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.425207e-02 | 1.266 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.744005e-02 | 1.324 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.087631e-02 | 1.293 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.893466e-02 | 1.310 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.689196e-02 | 1.245 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.920224e-02 | 1.308 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.464268e-02 | 1.262 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.689196e-02 | 1.245 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.300646e-02 | 1.366 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.924973e-02 | 1.308 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 5.307488e-02 | 1.275 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.054177e-02 | 1.296 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.884410e-02 | 1.311 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.384155e-02 | 1.269 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.407169e-02 | 1.356 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.382534e-02 | 1.358 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.492198e-02 | 1.348 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.320759e-02 | 1.274 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.074383e-02 | 1.295 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.734852e-02 | 1.241 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.752325e-02 | 1.240 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.752325e-02 | 1.240 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.752325e-02 | 1.240 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.752325e-02 | 1.240 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.752325e-02 | 1.240 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.761252e-02 | 1.239 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.852866e-02 | 1.233 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.852866e-02 | 1.233 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.054718e-02 | 1.218 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.072908e-02 | 1.217 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.226099e-02 | 1.206 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.413340e-02 | 1.193 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.413340e-02 | 1.193 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.416095e-02 | 1.193 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.416095e-02 | 1.193 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.416095e-02 | 1.193 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.416095e-02 | 1.193 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.618605e-02 | 1.179 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.618605e-02 | 1.179 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.621407e-02 | 1.179 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.711503e-02 | 1.173 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.929435e-02 | 1.159 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.929435e-02 | 1.159 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.982662e-02 | 1.156 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.092811e-02 | 1.149 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.168470e-02 | 1.145 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.217348e-02 | 1.142 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.217348e-02 | 1.142 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.217348e-02 | 1.142 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.528921e-02 | 1.123 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.560884e-02 | 1.121 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.560884e-02 | 1.121 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.560884e-02 | 1.121 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.560884e-02 | 1.121 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.656148e-02 | 1.116 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.120914e-02 | 1.040 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.120914e-02 | 1.040 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.120914e-02 | 1.040 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 9.120914e-02 | 1.040 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.120914e-02 | 1.040 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 9.120914e-02 | 1.040 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 9.120914e-02 | 1.040 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 9.120914e-02 | 1.040 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.120914e-02 | 1.040 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 9.120914e-02 | 1.040 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 9.120914e-02 | 1.040 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 9.120914e-02 | 1.040 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 9.120914e-02 | 1.040 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.361003e-02 | 1.078 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.361003e-02 | 1.078 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.361003e-02 | 1.078 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.361003e-02 | 1.078 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 9.813497e-02 | 1.008 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 9.813497e-02 | 1.008 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 9.813497e-02 | 1.008 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.813497e-02 | 1.008 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.813497e-02 | 1.008 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.133023e-01 | 0.946 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.133023e-01 | 0.946 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.133023e-01 | 0.946 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.998100e-02 | 1.046 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.998100e-02 | 1.046 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.092224e-01 | 0.962 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.220241e-02 | 1.085 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.220241e-02 | 1.085 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.906897e-02 | 1.050 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.620182e-02 | 1.017 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.620182e-02 | 1.017 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.035936e-01 | 0.985 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.035936e-01 | 0.985 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.054080e-01 | 0.977 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.054080e-01 | 0.977 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.169426e-02 | 1.088 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.133023e-01 | 0.946 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 9.813497e-02 | 1.008 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.855742e-02 | 1.053 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.133023e-01 | 0.946 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.941283e-02 | 1.003 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.620182e-02 | 1.017 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.567701e-02 | 1.067 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.131232e-01 | 0.946 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.109364e-01 | 0.955 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.109364e-01 | 0.955 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.109364e-01 | 0.955 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.109364e-01 | 0.955 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.941283e-02 | 1.003 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.962161e-02 | 1.002 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.133023e-01 | 0.946 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.276929e-02 | 1.033 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.289687e-02 | 1.081 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 9.120914e-02 | 1.040 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 9.813497e-02 | 1.008 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.133023e-01 | 0.946 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.109364e-01 | 0.955 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.118699e-01 | 0.951 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.906897e-02 | 1.050 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.169426e-02 | 1.088 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.166955e-02 | 1.038 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.166955e-02 | 1.038 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.441364e-02 | 1.025 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.743476e-02 | 1.111 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.743476e-02 | 1.111 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.830165e-02 | 1.054 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.133023e-01 | 0.946 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.941283e-02 | 1.003 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.133023e-01 | 0.946 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.030270e-01 | 0.987 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 8.361003e-02 | 1.078 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.133023e-01 | 0.946 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.941283e-02 | 1.003 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.941283e-02 | 1.003 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.395881e-02 | 1.076 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.361003e-02 | 1.078 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.133023e-01 | 0.946 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.112365e-01 | 0.954 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.024275e-01 | 0.990 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.872160e-02 | 1.052 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.092224e-01 | 0.962 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.952610e-02 | 1.048 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.155202e-01 | 0.937 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 1.166098e-01 | 0.933 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.166098e-01 | 0.933 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.191222e-01 | 0.924 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.191222e-01 | 0.924 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.191222e-01 | 0.924 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.193880e-01 | 0.923 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.193880e-01 | 0.923 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.193880e-01 | 0.923 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.193880e-01 | 0.923 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.193880e-01 | 0.923 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.197273e-01 | 0.922 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.197273e-01 | 0.922 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.224257e-01 | 0.912 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.261329e-01 | 0.899 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.265082e-01 | 0.898 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.272419e-01 | 0.895 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.272419e-01 | 0.895 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.272419e-01 | 0.895 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.272419e-01 | 0.895 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.283815e-01 | 0.891 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.283815e-01 | 0.891 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.290206e-01 | 0.889 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.290206e-01 | 0.889 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.290206e-01 | 0.889 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.290206e-01 | 0.889 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.290206e-01 | 0.889 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.290206e-01 | 0.889 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.298874e-01 | 0.886 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.298874e-01 | 0.886 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.298874e-01 | 0.886 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.332592e-01 | 0.875 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.334611e-01 | 0.875 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 1.336488e-01 | 0.874 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.336488e-01 | 0.874 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 1.336488e-01 | 0.874 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 1.336488e-01 | 0.874 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.336488e-01 | 0.874 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.336488e-01 | 0.874 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 1.336488e-01 | 0.874 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 1.336488e-01 | 0.874 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.336488e-01 | 0.874 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.336488e-01 | 0.874 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 1.336488e-01 | 0.874 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.336488e-01 | 0.874 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.336488e-01 | 0.874 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.336488e-01 | 0.874 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.336488e-01 | 0.874 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.336488e-01 | 0.874 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.352341e-01 | 0.869 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.355864e-01 | 0.868 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 1.355864e-01 | 0.868 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.373368e-01 | 0.862 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.373368e-01 | 0.862 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.373368e-01 | 0.862 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.391192e-01 | 0.857 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.405813e-01 | 0.852 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.405813e-01 | 0.852 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.406981e-01 | 0.852 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.406981e-01 | 0.852 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.414805e-01 | 0.849 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.438296e-01 | 0.842 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.441463e-01 | 0.841 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.443313e-01 | 0.841 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.452056e-01 | 0.838 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.452056e-01 | 0.838 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.452056e-01 | 0.838 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.452056e-01 | 0.838 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.452056e-01 | 0.838 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.452056e-01 | 0.838 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.452056e-01 | 0.838 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.452056e-01 | 0.838 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 1.452056e-01 | 0.838 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.741090e-01 | 0.759 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 2.126820e-01 | 0.672 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.126820e-01 | 0.672 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.126820e-01 | 0.672 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.494556e-01 | 0.603 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.494556e-01 | 0.603 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.494556e-01 | 0.603 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.494556e-01 | 0.603 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.494556e-01 | 0.603 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.494556e-01 | 0.603 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.494556e-01 | 0.603 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.494556e-01 | 0.603 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.845138e-01 | 0.546 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.845138e-01 | 0.546 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.845138e-01 | 0.546 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.845138e-01 | 0.546 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.845138e-01 | 0.546 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.845138e-01 | 0.546 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.617794e-01 | 0.791 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.617794e-01 | 0.791 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.786706e-01 | 0.748 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.131482e-01 | 0.671 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.517978e-01 | 0.819 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.306192e-01 | 0.637 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.306192e-01 | 0.637 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.631640e-01 | 0.787 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.747743e-01 | 0.758 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.481760e-01 | 0.605 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.866069e-01 | 0.729 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.657727e-01 | 0.575 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.986399e-01 | 0.702 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.618731e-01 | 0.791 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 2.108521e-01 | 0.676 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.833673e-01 | 0.548 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.833673e-01 | 0.548 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.357314e-01 | 0.628 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.898281e-01 | 0.722 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.092533e-01 | 0.679 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.357314e-01 | 0.628 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.483584e-01 | 0.605 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.483584e-01 | 0.605 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 2.092533e-01 | 0.679 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.898281e-01 | 0.722 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.292109e-01 | 0.640 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.958137e-01 | 0.708 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.483584e-01 | 0.605 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.898281e-01 | 0.722 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.517978e-01 | 0.819 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 2.738914e-01 | 0.562 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.690297e-01 | 0.570 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.833673e-01 | 0.548 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.803416e-01 | 0.744 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.618731e-01 | 0.791 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.657727e-01 | 0.575 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.477943e-01 | 0.606 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.617794e-01 | 0.791 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.786706e-01 | 0.748 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.786706e-01 | 0.748 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 2.657727e-01 | 0.575 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.657727e-01 | 0.575 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.610846e-01 | 0.583 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.908953e-01 | 0.536 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.496172e-01 | 0.603 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.706276e-01 | 0.768 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.292109e-01 | 0.640 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.494556e-01 | 0.603 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.958137e-01 | 0.708 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.092533e-01 | 0.679 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.191708e-01 | 0.659 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.946476e-01 | 0.711 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.867611e-01 | 0.542 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.867611e-01 | 0.542 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.499639e-01 | 0.824 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.264608e-01 | 0.645 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.949476e-01 | 0.710 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.786706e-01 | 0.748 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.958137e-01 | 0.708 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.494556e-01 | 0.603 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.494556e-01 | 0.603 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.845138e-01 | 0.546 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 2.306192e-01 | 0.637 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.481760e-01 | 0.605 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.264665e-01 | 0.645 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.946476e-01 | 0.711 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.738914e-01 | 0.562 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.657727e-01 | 0.575 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.322726e-01 | 0.634 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.357314e-01 | 0.628 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.494556e-01 | 0.603 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.494556e-01 | 0.603 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.845138e-01 | 0.546 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.617794e-01 | 0.791 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.617794e-01 | 0.791 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.617794e-01 | 0.791 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.617794e-01 | 0.791 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.618731e-01 | 0.791 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.496172e-01 | 0.603 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.496172e-01 | 0.603 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.370229e-01 | 0.625 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.546445e-01 | 0.594 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.867719e-01 | 0.542 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.994689e-01 | 0.700 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.529119e-01 | 0.816 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.264769e-01 | 0.645 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.845138e-01 | 0.546 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.866069e-01 | 0.729 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.357314e-01 | 0.628 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.610846e-01 | 0.583 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.898281e-01 | 0.722 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.494556e-01 | 0.603 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.786706e-01 | 0.748 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.786706e-01 | 0.748 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.786706e-01 | 0.748 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.833673e-01 | 0.548 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.597328e-01 | 0.585 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.977030e-01 | 0.526 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.475755e-01 | 0.606 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.060112e-01 | 0.686 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.867611e-01 | 0.542 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.092533e-01 | 0.679 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.545915e-01 | 0.594 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.635735e-01 | 0.579 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.503936e-01 | 0.823 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 2.126820e-01 | 0.672 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.494556e-01 | 0.603 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.845138e-01 | 0.546 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.481760e-01 | 0.605 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.481760e-01 | 0.605 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.481760e-01 | 0.605 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.657727e-01 | 0.575 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.867611e-01 | 0.542 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.496172e-01 | 0.603 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.769275e-01 | 0.752 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.529996e-01 | 0.815 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.914470e-01 | 0.535 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.201929e-01 | 0.657 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.657727e-01 | 0.575 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.618731e-01 | 0.791 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.108521e-01 | 0.676 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.992912e-01 | 0.524 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 1.986399e-01 | 0.702 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.829838e-01 | 0.738 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.393632e-01 | 0.621 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.716412e-01 | 0.765 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.557525e-01 | 0.808 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.557525e-01 | 0.808 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.557525e-01 | 0.808 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.741090e-01 | 0.759 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 2.126820e-01 | 0.672 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.494556e-01 | 0.603 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.845138e-01 | 0.546 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.845138e-01 | 0.546 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.845138e-01 | 0.546 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.786706e-01 | 0.748 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.866069e-01 | 0.729 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.898281e-01 | 0.722 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.994689e-01 | 0.700 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.191708e-01 | 0.659 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.877702e-01 | 0.541 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.023793e-01 | 0.694 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.264966e-01 | 0.645 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.867611e-01 | 0.542 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.867611e-01 | 0.542 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.020948e-01 | 0.694 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.867611e-01 | 0.542 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 2.679888e-01 | 0.572 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.523316e-01 | 0.598 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.722900e-01 | 0.565 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.845138e-01 | 0.546 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.631640e-01 | 0.787 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.657727e-01 | 0.575 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.599626e-01 | 0.585 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 2.690297e-01 | 0.570 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.499639e-01 | 0.824 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.481760e-01 | 0.605 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.985203e-01 | 0.525 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.958137e-01 | 0.708 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.995472e-01 | 0.524 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.868799e-01 | 0.542 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.803416e-01 | 0.744 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.866069e-01 | 0.729 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.631640e-01 | 0.787 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.061162e-01 | 0.686 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.867611e-01 | 0.542 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.996764e-01 | 0.523 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.996764e-01 | 0.523 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.996764e-01 | 0.523 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 2.996764e-01 | 0.523 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.999286e-01 | 0.523 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.009218e-01 | 0.522 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.009218e-01 | 0.522 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.009218e-01 | 0.522 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 3.009218e-01 | 0.522 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.009218e-01 | 0.522 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.072434e-01 | 0.513 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.124989e-01 | 0.505 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.126209e-01 | 0.505 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.126209e-01 | 0.505 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.126209e-01 | 0.505 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.127122e-01 | 0.505 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.135197e-01 | 0.504 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.165403e-01 | 0.500 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.179365e-01 | 0.498 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.179365e-01 | 0.498 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.179365e-01 | 0.498 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.179365e-01 | 0.498 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.179365e-01 | 0.498 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.179365e-01 | 0.498 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.179365e-01 | 0.498 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.179365e-01 | 0.498 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 3.179365e-01 | 0.498 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.179365e-01 | 0.498 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.179365e-01 | 0.498 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.179365e-01 | 0.498 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.179365e-01 | 0.498 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.179365e-01 | 0.498 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.179365e-01 | 0.498 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.179365e-01 | 0.498 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.179365e-01 | 0.498 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.184014e-01 | 0.497 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.184014e-01 | 0.497 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.184014e-01 | 0.497 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.184014e-01 | 0.497 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.190103e-01 | 0.496 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.233991e-01 | 0.490 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.233991e-01 | 0.490 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.255787e-01 | 0.487 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.255787e-01 | 0.487 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.255787e-01 | 0.487 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.255787e-01 | 0.487 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.261743e-01 | 0.487 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.286533e-01 | 0.483 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.327495e-01 | 0.478 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.341102e-01 | 0.476 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.385349e-01 | 0.470 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.385349e-01 | 0.470 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.414812e-01 | 0.467 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.497998e-01 | 0.456 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.497998e-01 | 0.456 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.497998e-01 | 0.456 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.497998e-01 | 0.456 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.502896e-01 | 0.456 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.530144e-01 | 0.452 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.530144e-01 | 0.452 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.530144e-01 | 0.452 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.556950e-01 | 0.449 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.643852e-01 | 0.438 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.643852e-01 | 0.438 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.663016e-01 | 0.436 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.663016e-01 | 0.436 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.669034e-01 | 0.435 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.669034e-01 | 0.435 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.689057e-01 | 0.433 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.698953e-01 | 0.432 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.700943e-01 | 0.432 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.700943e-01 | 0.432 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.700943e-01 | 0.432 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.700943e-01 | 0.432 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.700943e-01 | 0.432 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.700943e-01 | 0.432 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.770239e-01 | 0.424 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.770239e-01 | 0.424 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.772528e-01 | 0.423 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.772528e-01 | 0.423 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.772528e-01 | 0.423 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.796783e-01 | 0.421 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.801764e-01 | 0.420 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.801764e-01 | 0.420 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.801764e-01 | 0.420 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.801764e-01 | 0.420 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 3.801764e-01 | 0.420 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.801764e-01 | 0.420 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.801764e-01 | 0.420 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.801764e-01 | 0.420 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.801764e-01 | 0.420 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.801764e-01 | 0.420 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.801764e-01 | 0.420 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.801764e-01 | 0.420 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.801764e-01 | 0.420 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.801764e-01 | 0.420 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.869919e-01 | 0.412 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.869919e-01 | 0.412 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.869919e-01 | 0.412 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.900653e-01 | 0.409 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.900653e-01 | 0.409 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.900653e-01 | 0.409 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.913312e-01 | 0.407 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.984095e-01 | 0.400 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.987039e-01 | 0.399 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.028112e-01 | 0.395 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.028112e-01 | 0.395 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.036871e-01 | 0.394 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.036871e-01 | 0.394 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.091356e-01 | 0.388 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.091356e-01 | 0.388 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.091356e-01 | 0.388 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.091356e-01 | 0.388 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.091356e-01 | 0.388 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.091356e-01 | 0.388 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.091356e-01 | 0.388 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.091356e-01 | 0.388 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.091356e-01 | 0.388 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.149967e-01 | 0.382 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.154796e-01 | 0.381 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.154796e-01 | 0.381 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.154796e-01 | 0.381 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.154796e-01 | 0.381 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.175531e-01 | 0.379 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.196678e-01 | 0.377 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.196678e-01 | 0.377 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.201619e-01 | 0.377 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.238895e-01 | 0.373 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.280601e-01 | 0.368 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.302321e-01 | 0.366 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.364005e-01 | 0.360 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.364005e-01 | 0.360 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.364005e-01 | 0.360 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.367434e-01 | 0.360 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.367434e-01 | 0.360 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.367434e-01 | 0.360 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.367434e-01 | 0.360 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.367434e-01 | 0.360 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.367434e-01 | 0.360 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.367434e-01 | 0.360 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.367434e-01 | 0.360 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.367434e-01 | 0.360 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.367434e-01 | 0.360 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.456180e-01 | 0.351 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.463840e-01 | 0.350 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.463840e-01 | 0.350 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.511992e-01 | 0.346 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.511992e-01 | 0.346 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.523890e-01 | 0.344 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.523890e-01 | 0.344 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.523890e-01 | 0.344 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.523890e-01 | 0.344 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.523890e-01 | 0.344 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.529198e-01 | 0.344 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.529198e-01 | 0.344 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.529198e-01 | 0.344 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.630629e-01 | 0.334 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.630629e-01 | 0.334 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.630629e-01 | 0.334 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.630629e-01 | 0.334 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.630629e-01 | 0.334 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.630629e-01 | 0.334 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.630629e-01 | 0.334 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.630629e-01 | 0.334 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.651817e-01 | 0.332 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.681154e-01 | 0.330 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.681154e-01 | 0.330 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.681154e-01 | 0.330 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.681154e-01 | 0.330 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.697462e-01 | 0.328 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.818535e-01 | 0.317 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.835692e-01 | 0.316 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.835692e-01 | 0.316 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.835692e-01 | 0.316 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.835692e-01 | 0.316 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.881541e-01 | 0.311 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.881541e-01 | 0.311 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.881541e-01 | 0.311 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.881541e-01 | 0.311 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 4.881541e-01 | 0.311 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.881541e-01 | 0.311 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.881541e-01 | 0.311 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.881541e-01 | 0.311 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 4.881541e-01 | 0.311 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.893303e-01 | 0.310 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.987417e-01 | 0.302 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.987417e-01 | 0.302 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.987417e-01 | 0.302 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.118465e-01 | 0.291 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.120742e-01 | 0.291 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.120742e-01 | 0.291 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.120742e-01 | 0.291 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.120742e-01 | 0.291 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.120742e-01 | 0.291 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 5.120742e-01 | 0.291 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.120742e-01 | 0.291 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.120742e-01 | 0.291 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.120742e-01 | 0.291 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.120742e-01 | 0.291 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.124041e-01 | 0.290 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.124041e-01 | 0.290 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.124041e-01 | 0.290 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.129336e-01 | 0.290 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.129336e-01 | 0.290 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.136253e-01 | 0.289 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.136253e-01 | 0.289 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.223058e-01 | 0.282 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.245158e-01 | 0.280 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.245158e-01 | 0.280 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.264296e-01 | 0.279 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.282139e-01 | 0.277 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.348778e-01 | 0.272 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.348778e-01 | 0.272 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.348778e-01 | 0.272 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.348778e-01 | 0.272 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.348778e-01 | 0.272 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.348778e-01 | 0.272 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.348778e-01 | 0.272 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.348778e-01 | 0.272 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.348778e-01 | 0.272 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.348778e-01 | 0.272 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.348778e-01 | 0.272 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.348778e-01 | 0.272 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.348778e-01 | 0.272 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.348778e-01 | 0.272 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.382296e-01 | 0.269 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.389865e-01 | 0.268 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.418151e-01 | 0.266 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.425027e-01 | 0.266 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.425027e-01 | 0.266 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.425027e-01 | 0.266 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.450449e-01 | 0.264 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.472160e-01 | 0.262 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.514155e-01 | 0.259 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.514155e-01 | 0.259 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.514155e-01 | 0.259 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.524293e-01 | 0.258 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.553102e-01 | 0.255 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.564877e-01 | 0.255 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.564877e-01 | 0.255 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.564877e-01 | 0.255 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.564877e-01 | 0.255 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.566170e-01 | 0.254 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 5.566170e-01 | 0.254 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.566170e-01 | 0.254 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.566170e-01 | 0.254 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.566170e-01 | 0.254 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 5.566170e-01 | 0.254 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.566170e-01 | 0.254 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.566170e-01 | 0.254 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 5.566170e-01 | 0.254 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.566170e-01 | 0.254 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 5.566170e-01 | 0.254 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.566170e-01 | 0.254 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.566170e-01 | 0.254 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.583252e-01 | 0.253 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.583252e-01 | 0.253 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.590899e-01 | 0.253 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.607412e-01 | 0.251 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.609088e-01 | 0.251 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.637331e-01 | 0.249 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.657079e-01 | 0.247 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.692688e-01 | 0.245 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.692688e-01 | 0.245 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.701662e-01 | 0.244 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.720744e-01 | 0.243 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.773414e-01 | 0.239 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.773414e-01 | 0.239 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.773414e-01 | 0.239 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.773414e-01 | 0.239 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.773414e-01 | 0.239 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.773414e-01 | 0.239 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.773414e-01 | 0.239 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.773414e-01 | 0.239 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.773414e-01 | 0.239 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.773414e-01 | 0.239 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.773414e-01 | 0.239 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.773414e-01 | 0.239 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 5.773414e-01 | 0.239 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.773414e-01 | 0.239 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.800434e-01 | 0.237 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.800434e-01 | 0.237 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.803321e-01 | 0.236 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.835362e-01 | 0.234 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.835362e-01 | 0.234 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.835362e-01 | 0.234 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.835362e-01 | 0.234 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.852936e-01 | 0.233 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.906463e-01 | 0.229 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.906463e-01 | 0.229 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.965882e-01 | 0.224 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.970983e-01 | 0.224 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.970983e-01 | 0.224 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.970983e-01 | 0.224 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.970983e-01 | 0.224 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.970983e-01 | 0.224 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.970983e-01 | 0.224 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.970983e-01 | 0.224 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.970983e-01 | 0.224 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.970983e-01 | 0.224 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.970983e-01 | 0.224 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.970983e-01 | 0.224 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.970983e-01 | 0.224 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.970983e-01 | 0.224 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.981148e-01 | 0.223 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.010750e-01 | 0.221 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 6.010750e-01 | 0.221 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.093475e-01 | 0.215 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.093475e-01 | 0.215 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.093475e-01 | 0.215 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.093475e-01 | 0.215 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.113273e-01 | 0.214 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.159329e-01 | 0.210 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.159329e-01 | 0.210 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.159329e-01 | 0.210 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 6.159329e-01 | 0.210 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.159329e-01 | 0.210 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.159329e-01 | 0.210 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.159329e-01 | 0.210 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.159329e-01 | 0.210 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.159329e-01 | 0.210 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.159329e-01 | 0.210 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.159329e-01 | 0.210 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.159329e-01 | 0.210 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.159329e-01 | 0.210 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.169701e-01 | 0.210 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.203043e-01 | 0.207 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.214016e-01 | 0.207 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.214016e-01 | 0.207 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.214016e-01 | 0.207 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 6.217889e-01 | 0.206 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.326870e-01 | 0.199 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.338880e-01 | 0.198 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.338880e-01 | 0.198 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.338880e-01 | 0.198 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 6.338880e-01 | 0.198 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 6.338880e-01 | 0.198 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.338880e-01 | 0.198 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.338880e-01 | 0.198 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.339219e-01 | 0.198 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 6.339219e-01 | 0.198 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 6.339219e-01 | 0.198 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 6.410105e-01 | 0.193 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.457483e-01 | 0.190 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.495623e-01 | 0.187 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.505433e-01 | 0.187 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.505868e-01 | 0.187 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.510048e-01 | 0.186 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.510048e-01 | 0.186 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.510048e-01 | 0.186 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.510048e-01 | 0.186 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.510048e-01 | 0.186 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.510048e-01 | 0.186 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.572702e-01 | 0.182 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.572702e-01 | 0.182 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.572702e-01 | 0.182 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.598942e-01 | 0.181 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.651441e-01 | 0.177 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.673223e-01 | 0.176 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.673223e-01 | 0.176 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 6.673223e-01 | 0.176 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.673223e-01 | 0.176 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.673223e-01 | 0.176 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.673223e-01 | 0.176 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.673223e-01 | 0.176 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.673223e-01 | 0.176 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.673223e-01 | 0.176 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 6.684901e-01 | 0.175 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.793006e-01 | 0.168 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.793006e-01 | 0.168 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.794111e-01 | 0.168 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.794111e-01 | 0.168 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.794111e-01 | 0.168 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.794111e-01 | 0.168 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.828779e-01 | 0.166 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.828779e-01 | 0.166 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.828779e-01 | 0.166 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.828779e-01 | 0.166 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.828779e-01 | 0.166 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.828779e-01 | 0.166 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.828779e-01 | 0.166 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.828779e-01 | 0.166 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.828779e-01 | 0.166 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.828779e-01 | 0.166 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.828779e-01 | 0.166 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.856308e-01 | 0.164 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 6.874163e-01 | 0.163 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.889347e-01 | 0.162 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.900367e-01 | 0.161 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.900367e-01 | 0.161 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.900367e-01 | 0.161 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.954775e-01 | 0.158 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.977069e-01 | 0.156 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.977069e-01 | 0.156 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.977069e-01 | 0.156 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.977069e-01 | 0.156 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.977069e-01 | 0.156 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 6.977069e-01 | 0.156 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.977069e-01 | 0.156 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.977069e-01 | 0.156 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.977069e-01 | 0.156 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.977069e-01 | 0.156 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 6.977069e-01 | 0.156 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.977069e-01 | 0.156 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.977069e-01 | 0.156 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.977069e-01 | 0.156 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.977069e-01 | 0.156 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.977069e-01 | 0.156 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.977069e-01 | 0.156 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.003706e-01 | 0.155 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.050670e-01 | 0.152 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.063944e-01 | 0.151 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 7.104167e-01 | 0.148 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.104167e-01 | 0.148 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.104167e-01 | 0.148 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 7.118434e-01 | 0.148 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.118434e-01 | 0.148 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.118434e-01 | 0.148 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.118434e-01 | 0.148 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 7.118434e-01 | 0.148 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.118434e-01 | 0.148 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.118434e-01 | 0.148 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.118434e-01 | 0.148 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.118434e-01 | 0.148 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.121826e-01 | 0.147 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.182121e-01 | 0.144 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.201795e-01 | 0.143 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.253197e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.253197e-01 | 0.139 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.253197e-01 | 0.139 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.253197e-01 | 0.139 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.253197e-01 | 0.139 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.253197e-01 | 0.139 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.256390e-01 | 0.139 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.281724e-01 | 0.138 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.296634e-01 | 0.137 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.296634e-01 | 0.137 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.296634e-01 | 0.137 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.296634e-01 | 0.137 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.381665e-01 | 0.132 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.381665e-01 | 0.132 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.381665e-01 | 0.132 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.381665e-01 | 0.132 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.381665e-01 | 0.132 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.381665e-01 | 0.132 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.381665e-01 | 0.132 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.381665e-01 | 0.132 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.381665e-01 | 0.132 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.381665e-01 | 0.132 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.381665e-01 | 0.132 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 7.388731e-01 | 0.131 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.434573e-01 | 0.129 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.439607e-01 | 0.128 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.439607e-01 | 0.128 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.478136e-01 | 0.126 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.478136e-01 | 0.126 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.500722e-01 | 0.125 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.504131e-01 | 0.125 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.504131e-01 | 0.125 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.504131e-01 | 0.125 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.504131e-01 | 0.125 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.564898e-01 | 0.121 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.580499e-01 | 0.120 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.580499e-01 | 0.120 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.620877e-01 | 0.118 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.620877e-01 | 0.118 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.620877e-01 | 0.118 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.620877e-01 | 0.118 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.620877e-01 | 0.118 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.620877e-01 | 0.118 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.649070e-01 | 0.116 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.730703e-01 | 0.112 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.732169e-01 | 0.112 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.732169e-01 | 0.112 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.732169e-01 | 0.112 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.732169e-01 | 0.112 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.732169e-01 | 0.112 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 7.732169e-01 | 0.112 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.732169e-01 | 0.112 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.732169e-01 | 0.112 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.732169e-01 | 0.112 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.732169e-01 | 0.112 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.732169e-01 | 0.112 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.786732e-01 | 0.109 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.786732e-01 | 0.109 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.809851e-01 | 0.107 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.838261e-01 | 0.106 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 7.838261e-01 | 0.106 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.838261e-01 | 0.106 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.881056e-01 | 0.103 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.883667e-01 | 0.103 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.916025e-01 | 0.101 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.939396e-01 | 0.100 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.939396e-01 | 0.100 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.939396e-01 | 0.100 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.939396e-01 | 0.100 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.939396e-01 | 0.100 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.939396e-01 | 0.100 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.939396e-01 | 0.100 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.952711e-01 | 0.099 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.978280e-01 | 0.098 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.982205e-01 | 0.098 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.984796e-01 | 0.098 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.991992e-01 | 0.097 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.991992e-01 | 0.097 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.033917e-01 | 0.095 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.035805e-01 | 0.095 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.035805e-01 | 0.095 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.035805e-01 | 0.095 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.035805e-01 | 0.095 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 8.035805e-01 | 0.095 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.035805e-01 | 0.095 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.035805e-01 | 0.095 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.098190e-01 | 0.092 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.102670e-01 | 0.091 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.102670e-01 | 0.091 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.102670e-01 | 0.091 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.108363e-01 | 0.091 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.108363e-01 | 0.091 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.127710e-01 | 0.090 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.127710e-01 | 0.090 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.127710e-01 | 0.090 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.127710e-01 | 0.090 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.127710e-01 | 0.090 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.127710e-01 | 0.090 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.132678e-01 | 0.090 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.149547e-01 | 0.089 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.155768e-01 | 0.089 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.189035e-01 | 0.087 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.199761e-01 | 0.086 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.215319e-01 | 0.085 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.215319e-01 | 0.085 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.215319e-01 | 0.085 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.215319e-01 | 0.085 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.215319e-01 | 0.085 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.215319e-01 | 0.085 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 8.215319e-01 | 0.085 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.217366e-01 | 0.085 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.219627e-01 | 0.085 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.235577e-01 | 0.084 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.235577e-01 | 0.084 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.235577e-01 | 0.084 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.298834e-01 | 0.081 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.298834e-01 | 0.081 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.298834e-01 | 0.081 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.298834e-01 | 0.081 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.298834e-01 | 0.081 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.298846e-01 | 0.081 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.343700e-01 | 0.079 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.351643e-01 | 0.078 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.360062e-01 | 0.078 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.360062e-01 | 0.078 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.378446e-01 | 0.077 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 8.378446e-01 | 0.077 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.419281e-01 | 0.075 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.419281e-01 | 0.075 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.422155e-01 | 0.075 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.434226e-01 | 0.074 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.434226e-01 | 0.074 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.454337e-01 | 0.073 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.454337e-01 | 0.073 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.454337e-01 | 0.073 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.454337e-01 | 0.073 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.476554e-01 | 0.072 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.519015e-01 | 0.070 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.526680e-01 | 0.069 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.526680e-01 | 0.069 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.526680e-01 | 0.069 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.551905e-01 | 0.068 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.565473e-01 | 0.067 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.595641e-01 | 0.066 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.595641e-01 | 0.066 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.595641e-01 | 0.066 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.595641e-01 | 0.066 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.595641e-01 | 0.066 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.595641e-01 | 0.066 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.595641e-01 | 0.066 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.595641e-01 | 0.066 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.595641e-01 | 0.066 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.595641e-01 | 0.066 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.610651e-01 | 0.065 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.637220e-01 | 0.064 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.642460e-01 | 0.063 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.654576e-01 | 0.063 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.661379e-01 | 0.062 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.661379e-01 | 0.062 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.661379e-01 | 0.062 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.718867e-01 | 0.060 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.724043e-01 | 0.059 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.724043e-01 | 0.059 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.724043e-01 | 0.059 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.724043e-01 | 0.059 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.724043e-01 | 0.059 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.779096e-01 | 0.057 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.783778e-01 | 0.056 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.783778e-01 | 0.056 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.818271e-01 | 0.055 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.818271e-01 | 0.055 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.840719e-01 | 0.054 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.840719e-01 | 0.054 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.840719e-01 | 0.054 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.870829e-01 | 0.052 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.893279e-01 | 0.051 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.894998e-01 | 0.051 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.894998e-01 | 0.051 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.946738e-01 | 0.048 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.946738e-01 | 0.048 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.946738e-01 | 0.048 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.946738e-01 | 0.048 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.953433e-01 | 0.048 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.953433e-01 | 0.048 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.953433e-01 | 0.048 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.996059e-01 | 0.046 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.996059e-01 | 0.046 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.997813e-01 | 0.046 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.007268e-01 | 0.045 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.030386e-01 | 0.044 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.030630e-01 | 0.044 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.043073e-01 | 0.044 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.056935e-01 | 0.043 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.087889e-01 | 0.042 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.093368e-01 | 0.041 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.112120e-01 | 0.040 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.130608e-01 | 0.040 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.130608e-01 | 0.040 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.130608e-01 | 0.040 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.135966e-01 | 0.039 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.135966e-01 | 0.039 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.168694e-01 | 0.038 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.200256e-01 | 0.036 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.210144e-01 | 0.036 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.210144e-01 | 0.036 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.210144e-01 | 0.036 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.210144e-01 | 0.036 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.210144e-01 | 0.036 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.210144e-01 | 0.036 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.234412e-01 | 0.035 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.247144e-01 | 0.034 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.247144e-01 | 0.034 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.247144e-01 | 0.034 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.282413e-01 | 0.032 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.282413e-01 | 0.032 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.316032e-01 | 0.031 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.324921e-01 | 0.030 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.341830e-01 | 0.030 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.348077e-01 | 0.029 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.355104e-01 | 0.029 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.378623e-01 | 0.028 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.391527e-01 | 0.027 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.406424e-01 | 0.027 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.407740e-01 | 0.027 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.407740e-01 | 0.027 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.407740e-01 | 0.027 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.415020e-01 | 0.026 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.435494e-01 | 0.025 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.435494e-01 | 0.025 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.435494e-01 | 0.025 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.458024e-01 | 0.024 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.458024e-01 | 0.024 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.461949e-01 | 0.024 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.500645e-01 | 0.022 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.511202e-01 | 0.022 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.529142e-01 | 0.021 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.539652e-01 | 0.020 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.555951e-01 | 0.020 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.556872e-01 | 0.020 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.561341e-01 | 0.019 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.596609e-01 | 0.018 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.596609e-01 | 0.018 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.615522e-01 | 0.017 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.619344e-01 | 0.017 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.633549e-01 | 0.016 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.637368e-01 | 0.016 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.650731e-01 | 0.015 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.650731e-01 | 0.015 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.667109e-01 | 0.015 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.678715e-01 | 0.014 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.682720e-01 | 0.014 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.687388e-01 | 0.014 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.711783e-01 | 0.013 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.725286e-01 | 0.012 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.725301e-01 | 0.012 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.725301e-01 | 0.012 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.725301e-01 | 0.012 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.762174e-01 | 0.010 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.769548e-01 | 0.010 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.773332e-01 | 0.010 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.773332e-01 | 0.010 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.773332e-01 | 0.010 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.773332e-01 | 0.010 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.773332e-01 | 0.010 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.773332e-01 | 0.010 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.783967e-01 | 0.009 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.783967e-01 | 0.009 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.794103e-01 | 0.009 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.803080e-01 | 0.009 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.812973e-01 | 0.008 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.833469e-01 | 0.007 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.836219e-01 | 0.007 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.836673e-01 | 0.007 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.838090e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.838090e-01 | 0.007 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.845689e-01 | 0.007 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.846279e-01 | 0.007 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.865251e-01 | 0.006 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.869269e-01 | 0.006 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.874772e-01 | 0.005 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.878787e-01 | 0.005 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.880310e-01 | 0.005 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.889794e-01 | 0.005 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.894969e-01 | 0.005 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.904603e-01 | 0.004 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.905118e-01 | 0.004 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.907126e-01 | 0.004 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.922311e-01 | 0.003 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.923335e-01 | 0.003 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.928525e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.931883e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.931883e-01 | 0.003 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.938134e-01 | 0.003 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.968756e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.970167e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.972717e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.979121e-01 | 0.001 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.981446e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.981446e-01 | 0.001 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.982051e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.984701e-01 | 0.001 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.986107e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.987385e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.990089e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.991424e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.991697e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.995829e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.996039e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.996404e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.997176e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.997448e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.997609e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999189e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999195e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999235e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999428e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999749e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999772e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999903e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999941e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999994e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.110223e-16 | 15.955 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.110223e-16 | 15.955 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.110223e-16 | 15.955 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.110223e-16 | 15.955 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.110223e-16 | 15.955 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.110223e-16 | 15.955 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.110223e-16 | 15.955 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.110223e-16 | 15.955 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.110223e-16 | 15.955 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.110223e-16 | 15.955 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.220446e-16 | 15.654 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.220446e-16 | 15.654 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.330669e-16 | 15.477 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.440892e-16 | 15.353 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.551115e-16 | 15.256 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.661338e-16 | 15.176 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.771561e-16 | 15.109 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.221245e-15 | 14.913 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.776357e-15 | 14.750 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.220446e-15 | 14.654 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.775558e-15 | 14.557 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.441691e-15 | 14.463 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.662937e-15 | 14.331 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.551115e-15 | 14.256 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.343370e-14 | 13.872 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.409983e-14 | 13.851 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.454392e-14 | 13.837 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.731948e-14 | 13.761 | 1 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.375877e-14 | 13.624 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.808864e-14 | 13.551 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.374279e-14 | 13.359 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.662137e-14 | 13.247 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.460699e-14 | 13.127 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.062483e-13 | 12.974 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.109113e-13 | 12.955 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.123546e-13 | 12.949 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.123546e-13 | 12.949 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.318945e-13 | 12.880 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.449951e-13 | 12.839 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.465494e-13 | 12.834 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.508793e-13 | 12.821 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.897682e-13 | 12.538 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.907186e-13 | 12.309 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.280221e-13 | 12.277 | 1 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.242784e-13 | 12.205 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.260548e-13 | 12.203 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.457057e-13 | 12.190 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.273071e-13 | 12.138 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.566792e-13 | 12.019 | 0 | 0 |
| Translation | R-HSA-72766 | 1.406320e-12 | 11.852 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.307377e-12 | 11.637 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.770451e-12 | 11.557 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.438139e-12 | 11.464 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.734013e-12 | 11.428 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.105139e-12 | 11.292 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.433076e-12 | 11.192 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.028921e-11 | 10.988 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.195932e-11 | 10.922 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.332545e-11 | 10.875 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.338685e-11 | 10.873 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.347844e-11 | 10.870 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.414879e-11 | 10.849 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.449962e-11 | 10.839 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.513145e-11 | 10.820 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.645639e-11 | 10.784 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.240030e-11 | 10.650 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.433154e-11 | 10.614 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.433154e-11 | 10.614 | 1 | 1 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.481026e-11 | 10.605 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.512546e-11 | 10.600 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.796463e-11 | 10.553 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.224665e-11 | 10.492 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.692247e-11 | 10.433 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.592993e-11 | 10.445 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.695033e-11 | 10.432 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.721778e-11 | 10.429 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.028777e-11 | 10.395 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.112333e-11 | 10.214 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.296563e-11 | 10.137 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.672740e-11 | 10.062 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.160472e-11 | 10.038 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.162190e-10 | 9.935 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.180619e-10 | 9.928 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.218151e-10 | 9.914 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.262492e-10 | 9.899 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.612687e-10 | 9.792 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.679233e-10 | 9.775 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.854396e-10 | 9.732 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.078107e-10 | 9.682 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.301077e-10 | 9.638 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.863756e-10 | 9.543 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.092666e-10 | 9.510 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.169606e-10 | 9.499 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.169606e-10 | 9.499 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.527428e-10 | 9.453 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.561339e-10 | 9.448 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.583983e-10 | 9.446 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.979821e-10 | 9.400 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.534713e-10 | 9.343 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.590902e-10 | 9.338 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.098717e-10 | 9.293 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.141039e-10 | 9.289 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.615552e-10 | 9.251 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.749592e-10 | 9.240 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.991971e-10 | 9.222 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.488687e-10 | 9.188 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.656699e-10 | 9.116 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.042661e-10 | 9.095 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.176203e-10 | 9.087 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.130277e-10 | 9.040 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.130277e-10 | 9.040 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.815144e-10 | 9.008 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.203111e-09 | 8.920 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.244180e-09 | 8.905 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.292291e-09 | 8.889 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.560872e-09 | 8.807 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.755863e-09 | 8.756 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.805737e-09 | 8.743 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.966802e-09 | 8.706 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.004943e-09 | 8.698 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.064782e-09 | 8.685 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.571994e-09 | 8.590 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.598718e-09 | 8.585 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.715503e-09 | 8.566 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.554552e-09 | 8.449 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.567278e-09 | 8.448 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.927692e-09 | 8.406 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.927692e-09 | 8.406 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.263911e-09 | 8.370 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.921608e-09 | 8.308 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.571148e-09 | 8.340 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.540363e-09 | 8.343 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.011041e-09 | 8.300 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.378028e-09 | 8.269 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.698380e-09 | 8.244 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.514376e-09 | 8.186 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.421455e-09 | 8.130 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.476257e-09 | 8.126 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.321777e-09 | 8.080 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.815254e-09 | 8.055 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.008806e-08 | 7.996 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.539967e-09 | 8.020 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.539967e-09 | 8.020 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.991400e-09 | 8.046 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.991400e-09 | 8.046 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.769548e-09 | 8.010 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.284395e-09 | 8.032 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.043265e-08 | 7.982 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.086211e-08 | 7.964 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.216676e-08 | 7.915 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.323574e-08 | 7.878 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.371024e-08 | 7.863 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.401607e-08 | 7.853 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.706439e-08 | 7.768 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.040851e-08 | 7.690 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.320846e-08 | 7.634 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.379070e-08 | 7.624 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.492586e-08 | 7.603 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.507859e-08 | 7.601 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.167773e-08 | 7.499 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.473202e-08 | 7.459 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.473202e-08 | 7.459 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.862491e-08 | 7.413 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.983126e-08 | 7.400 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.033628e-08 | 7.394 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.477859e-08 | 7.349 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.109445e-08 | 7.292 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.284062e-08 | 7.277 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.622478e-08 | 7.250 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.892198e-08 | 7.162 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.892198e-08 | 7.162 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.257515e-08 | 7.139 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.924362e-08 | 7.101 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.259284e-08 | 7.083 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.794439e-08 | 7.056 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.678121e-08 | 7.014 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.010354e-07 | 6.996 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.061986e-07 | 6.974 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.856404e-07 | 6.731 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.992663e-07 | 6.701 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.193507e-07 | 6.659 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.374599e-07 | 6.624 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.374599e-07 | 6.624 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.722380e-07 | 6.565 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.850696e-07 | 6.545 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.984302e-07 | 6.525 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.210830e-07 | 6.493 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.328626e-07 | 6.478 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.257090e-07 | 6.371 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.386323e-07 | 6.358 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.783573e-07 | 6.320 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.928911e-07 | 6.307 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 4.965557e-07 | 6.304 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.461613e-07 | 6.263 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.461613e-07 | 6.263 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.410463e-07 | 6.193 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.081899e-07 | 6.042 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.010139e-06 | 5.996 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.093147e-06 | 5.961 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.265067e-06 | 5.898 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.271299e-06 | 5.896 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.359851e-06 | 5.867 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.435896e-06 | 5.843 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.435896e-06 | 5.843 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.484895e-06 | 5.828 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.836378e-06 | 5.736 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.182230e-06 | 5.661 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.192660e-06 | 5.659 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.313126e-06 | 5.636 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.501897e-06 | 5.602 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.143439e-06 | 5.503 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.248185e-06 | 5.488 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.583296e-06 | 5.446 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.956717e-06 | 5.403 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.036108e-06 | 5.394 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.248862e-06 | 5.372 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.188648e-06 | 5.285 | 1 | 1 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.627428e-06 | 5.250 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.292814e-06 | 5.201 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.508773e-06 | 5.187 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.669015e-06 | 5.176 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.722070e-06 | 5.172 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.744713e-06 | 5.171 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.058913e-06 | 5.151 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.587795e-06 | 5.120 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.823592e-06 | 5.107 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.823592e-06 | 5.107 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.823592e-06 | 5.107 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.021412e-06 | 5.096 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.252558e-06 | 5.083 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.215989e-06 | 5.035 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.014576e-05 | 4.994 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.232350e-05 | 4.909 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.200140e-05 | 4.921 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.391908e-05 | 4.856 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.396231e-05 | 4.855 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.413970e-05 | 4.850 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.657863e-05 | 4.780 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.657863e-05 | 4.780 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.657863e-05 | 4.780 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.657863e-05 | 4.780 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.743390e-05 | 4.759 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.746628e-05 | 4.758 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.766657e-05 | 4.753 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.847803e-05 | 4.733 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.854446e-05 | 4.732 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.899780e-05 | 4.721 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.899780e-05 | 4.721 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.899780e-05 | 4.721 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.899780e-05 | 4.721 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.930071e-05 | 4.714 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.040895e-05 | 4.690 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.323502e-05 | 4.634 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.635851e-05 | 4.579 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.803739e-05 | 4.552 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.858976e-05 | 4.544 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.909207e-05 | 4.536 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.088326e-05 | 4.510 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.115038e-05 | 4.507 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.685928e-05 | 4.433 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.252638e-05 | 4.371 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.252638e-05 | 4.371 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.434657e-05 | 4.353 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.857477e-05 | 4.314 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.857477e-05 | 4.314 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.857477e-05 | 4.314 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.961391e-05 | 4.304 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.235591e-05 | 4.281 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.235591e-05 | 4.281 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.633299e-05 | 4.249 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.840440e-05 | 4.234 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.062081e-05 | 4.217 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.144250e-05 | 4.146 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.416981e-05 | 4.075 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.155530e-05 | 4.145 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 8.569197e-05 | 4.067 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.862193e-05 | 4.104 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.338741e-05 | 4.134 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.144250e-05 | 4.146 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.751940e-05 | 4.058 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.105657e-05 | 4.091 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.751940e-05 | 4.058 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.372933e-05 | 4.077 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.378198e-05 | 4.077 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.932893e-05 | 4.101 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.925341e-05 | 4.101 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.006255e-05 | 4.045 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.006255e-05 | 4.045 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.006255e-05 | 4.045 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.801492e-05 | 4.009 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.032976e-04 | 3.986 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.064424e-04 | 3.973 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.166909e-04 | 3.933 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.166909e-04 | 3.933 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.183625e-04 | 3.927 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.239098e-04 | 3.907 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.310569e-04 | 3.883 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.443041e-04 | 3.841 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.467765e-04 | 3.833 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.467765e-04 | 3.833 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.509154e-04 | 3.821 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.509154e-04 | 3.821 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.531662e-04 | 3.815 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.563784e-04 | 3.806 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.641021e-04 | 3.785 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.689956e-04 | 3.772 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.720537e-04 | 3.764 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.748076e-04 | 3.757 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.971102e-04 | 3.705 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.971102e-04 | 3.705 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.983045e-04 | 3.703 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.044934e-04 | 3.689 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.044934e-04 | 3.689 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.044934e-04 | 3.689 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.206334e-04 | 3.656 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.227774e-04 | 3.652 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.227774e-04 | 3.652 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.263328e-04 | 3.645 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.888417e-04 | 3.539 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.888417e-04 | 3.539 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.896816e-04 | 3.538 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.054383e-04 | 3.515 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.057308e-04 | 3.515 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.057308e-04 | 3.515 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.121264e-04 | 3.506 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.359566e-04 | 3.474 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.397634e-04 | 3.469 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.397634e-04 | 3.469 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.407100e-04 | 3.468 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.514050e-04 | 3.454 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.514050e-04 | 3.454 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 3.619892e-04 | 3.441 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 3.619892e-04 | 3.441 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.954023e-04 | 3.403 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.977718e-04 | 3.400 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.977718e-04 | 3.400 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.025666e-04 | 3.395 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.025666e-04 | 3.395 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.025666e-04 | 3.395 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.038485e-04 | 3.394 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.052615e-04 | 3.392 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.204584e-04 | 3.376 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.554516e-04 | 3.342 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.554516e-04 | 3.342 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.635850e-04 | 3.334 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.246039e-04 | 3.280 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.379642e-04 | 3.269 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.379642e-04 | 3.269 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.379642e-04 | 3.269 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.379642e-04 | 3.269 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.379642e-04 | 3.269 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.387278e-04 | 3.195 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.598971e-04 | 3.252 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.693856e-04 | 3.245 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.615357e-04 | 3.251 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.458161e-04 | 3.127 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.634281e-04 | 3.178 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.156814e-04 | 3.145 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.392063e-04 | 3.131 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.836106e-04 | 3.165 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.693856e-04 | 3.245 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.589217e-04 | 3.120 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.047060e-04 | 3.094 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.047060e-04 | 3.094 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.207577e-04 | 3.086 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.219723e-04 | 3.085 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 8.288932e-04 | 3.082 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.543433e-04 | 3.068 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.378760e-04 | 3.028 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.378760e-04 | 3.028 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.417055e-04 | 3.026 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.592948e-04 | 3.018 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.592948e-04 | 3.018 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.592948e-04 | 3.018 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 9.601639e-04 | 3.018 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.601639e-04 | 3.018 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.068012e-03 | 2.971 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.068012e-03 | 2.971 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.068012e-03 | 2.971 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.074467e-03 | 2.969 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.109477e-03 | 2.955 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.154688e-03 | 2.938 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.154688e-03 | 2.938 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.154688e-03 | 2.938 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.175385e-03 | 2.930 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.175385e-03 | 2.930 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.175385e-03 | 2.930 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.175385e-03 | 2.930 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.200579e-03 | 2.921 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.212182e-03 | 2.916 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.217200e-03 | 2.915 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.217200e-03 | 2.915 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.217200e-03 | 2.915 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.217200e-03 | 2.915 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.217200e-03 | 2.915 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.217200e-03 | 2.915 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.217200e-03 | 2.915 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.316364e-03 | 2.881 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.338378e-03 | 2.873 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.465323e-03 | 2.834 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.488639e-03 | 2.827 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.521844e-03 | 2.818 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.521844e-03 | 2.818 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.612373e-03 | 2.793 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.632277e-03 | 2.787 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.632277e-03 | 2.787 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.632277e-03 | 2.787 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.639894e-03 | 2.785 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.682768e-03 | 2.774 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.730961e-03 | 2.762 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.739672e-03 | 2.760 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.739672e-03 | 2.760 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.797546e-03 | 2.745 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.797546e-03 | 2.745 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.855581e-03 | 2.732 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.879136e-03 | 2.726 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.879136e-03 | 2.726 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.879136e-03 | 2.726 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.950947e-03 | 2.710 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.995974e-03 | 2.700 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.151120e-03 | 2.667 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.151120e-03 | 2.667 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.181929e-03 | 2.661 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.192276e-03 | 2.659 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.192276e-03 | 2.659 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.192276e-03 | 2.659 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.248171e-03 | 2.648 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.320450e-03 | 2.634 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.487939e-03 | 2.604 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.561730e-03 | 2.591 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.664498e-03 | 2.574 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.708022e-03 | 2.567 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.745460e-03 | 2.561 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.772242e-03 | 2.557 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.779704e-03 | 2.556 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.802686e-03 | 2.552 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.974751e-03 | 2.527 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.021266e-03 | 2.520 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.087806e-03 | 2.510 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.577821e-03 | 2.446 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.318462e-03 | 2.479 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.318462e-03 | 2.479 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.475904e-03 | 2.459 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.979527e-03 | 2.400 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.987362e-03 | 2.399 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.987362e-03 | 2.399 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.535203e-03 | 2.343 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.053483e-03 | 2.392 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.530374e-03 | 2.344 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.938087e-03 | 2.405 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.987362e-03 | 2.399 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.475904e-03 | 2.459 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.053483e-03 | 2.392 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.475904e-03 | 2.459 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.535203e-03 | 2.343 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.577821e-03 | 2.446 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.636312e-03 | 2.334 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.276092e-03 | 2.485 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.840533e-03 | 2.416 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.486889e-03 | 2.348 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.486889e-03 | 2.348 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.328277e-03 | 2.478 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.170425e-03 | 2.499 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.577821e-03 | 2.446 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.486889e-03 | 2.348 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.486889e-03 | 2.348 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.486889e-03 | 2.348 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.840533e-03 | 2.416 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.137084e-03 | 2.289 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.362636e-03 | 2.271 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.395173e-03 | 2.268 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.418281e-03 | 2.266 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.418281e-03 | 2.266 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 5.418281e-03 | 2.266 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.539791e-03 | 2.257 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.539791e-03 | 2.257 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.724365e-03 | 2.242 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.815048e-03 | 2.235 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.815048e-03 | 2.235 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.953114e-03 | 2.225 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.088628e-03 | 2.215 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.088628e-03 | 2.215 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.260263e-03 | 2.203 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.289061e-03 | 2.201 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.493911e-03 | 2.187 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.745914e-03 | 2.171 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.745914e-03 | 2.171 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.745914e-03 | 2.171 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.821212e-03 | 2.166 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 6.839258e-03 | 2.165 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 6.897884e-03 | 2.161 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.212412e-03 | 2.142 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.253623e-03 | 2.139 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.302729e-03 | 2.137 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.340083e-03 | 2.134 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.340083e-03 | 2.134 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.355605e-03 | 2.133 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.910718e-03 | 2.102 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.114077e-03 | 2.091 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.114077e-03 | 2.091 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.138147e-03 | 2.089 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.231924e-03 | 2.084 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.334774e-03 | 2.079 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.452518e-03 | 2.073 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.633990e-03 | 2.064 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.670554e-03 | 2.062 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.134705e-03 | 2.039 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.652498e-03 | 2.015 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 9.652498e-03 | 2.015 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.076785e-02 | 1.968 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.097688e-02 | 1.960 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.122275e-02 | 1.950 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.125335e-02 | 1.949 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.136876e-02 | 1.944 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.136876e-02 | 1.944 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.136876e-02 | 1.944 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.174846e-02 | 1.930 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.193866e-02 | 1.923 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.193866e-02 | 1.923 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.193866e-02 | 1.923 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.193866e-02 | 1.923 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.193866e-02 | 1.923 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.193866e-02 | 1.923 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.193866e-02 | 1.923 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.193866e-02 | 1.923 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.193866e-02 | 1.923 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.193866e-02 | 1.923 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.193866e-02 | 1.923 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.214445e-02 | 1.916 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.214445e-02 | 1.916 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.326979e-02 | 1.877 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.326979e-02 | 1.877 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.326979e-02 | 1.877 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.326979e-02 | 1.877 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.356999e-02 | 1.867 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.356999e-02 | 1.867 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.356999e-02 | 1.867 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.356999e-02 | 1.867 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.362721e-02 | 1.866 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.364758e-02 | 1.865 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.387319e-02 | 1.858 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.400571e-02 | 1.854 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.462766e-02 | 1.835 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.466699e-02 | 1.834 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.470022e-02 | 1.833 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.475114e-02 | 1.831 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.495499e-02 | 1.825 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.505879e-02 | 1.822 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.527113e-02 | 1.816 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.536186e-02 | 1.814 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.721877e-02 | 1.764 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.721877e-02 | 1.764 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.731168e-02 | 1.762 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.731168e-02 | 1.762 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.740232e-02 | 1.759 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.757731e-02 | 1.755 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.787470e-02 | 1.748 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.816664e-02 | 1.741 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.889430e-02 | 1.724 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.889430e-02 | 1.724 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.947158e-02 | 1.711 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.947158e-02 | 1.711 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.014073e-02 | 1.696 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.014073e-02 | 1.696 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.030842e-02 | 1.692 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.088560e-02 | 1.680 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.116293e-02 | 1.674 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 2.155333e-02 | 1.666 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.283668e-02 | 1.641 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.283668e-02 | 1.641 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.283668e-02 | 1.641 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.283668e-02 | 1.641 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.283668e-02 | 1.641 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.295098e-02 | 1.639 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.304126e-02 | 1.637 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.304126e-02 | 1.637 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.425140e-02 | 1.615 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.467890e-02 | 1.608 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.477349e-02 | 1.606 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.483782e-02 | 1.605 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.531862e-02 | 1.597 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.546736e-02 | 1.594 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.546736e-02 | 1.594 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.546736e-02 | 1.594 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.570198e-02 | 1.590 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.574192e-02 | 1.589 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.574192e-02 | 1.589 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.574192e-02 | 1.589 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.574192e-02 | 1.589 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 2.614999e-02 | 1.583 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.638234e-02 | 1.579 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.682542e-02 | 1.571 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.770141e-02 | 1.557 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.773537e-02 | 1.557 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.773537e-02 | 1.557 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.773537e-02 | 1.557 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.826096e-02 | 1.549 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.857744e-02 | 1.544 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.885935e-02 | 1.540 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.891564e-02 | 1.539 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.906357e-02 | 1.537 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.010812e-02 | 1.521 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.029379e-02 | 1.519 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.375680e-02 | 1.472 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 3.375680e-02 | 1.472 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.294077e-02 | 1.367 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.293472e-02 | 1.276 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.293472e-02 | 1.276 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.328431e-02 | 1.478 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.964189e-02 | 1.304 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.964189e-02 | 1.304 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.581673e-02 | 1.253 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.950406e-02 | 1.403 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.768608e-02 | 1.322 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.768608e-02 | 1.322 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.673374e-02 | 1.246 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.951106e-02 | 1.305 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.076381e-02 | 1.390 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.577572e-02 | 1.254 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.352972e-02 | 1.475 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.083195e-02 | 1.294 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.364680e-02 | 1.270 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.077436e-02 | 1.216 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.077436e-02 | 1.216 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.077436e-02 | 1.216 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.328431e-02 | 1.478 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.348644e-02 | 1.362 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.527220e-02 | 1.344 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.734290e-02 | 1.428 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.060246e-02 | 1.514 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.328431e-02 | 1.478 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.375680e-02 | 1.472 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.573912e-02 | 1.447 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.573912e-02 | 1.447 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.993984e-02 | 1.222 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.221904e-02 | 1.374 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.768608e-02 | 1.322 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.835434e-02 | 1.234 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 3.328431e-02 | 1.478 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.836800e-02 | 1.416 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.673374e-02 | 1.246 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.835434e-02 | 1.234 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.581673e-02 | 1.253 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.950406e-02 | 1.403 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.951106e-02 | 1.305 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.964189e-02 | 1.304 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.768608e-02 | 1.322 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.654892e-02 | 1.332 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.852860e-02 | 1.414 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.198051e-02 | 1.377 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.775858e-02 | 1.238 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.219122e-02 | 1.492 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 4.294077e-02 | 1.367 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.964189e-02 | 1.304 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.348644e-02 | 1.362 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.406334e-02 | 1.468 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.768608e-02 | 1.322 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.573912e-02 | 1.447 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.294077e-02 | 1.367 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.865541e-02 | 1.232 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.581862e-02 | 1.339 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 4.406390e-02 | 1.356 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.555792e-02 | 1.449 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.584345e-02 | 1.446 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.552769e-02 | 1.255 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.654892e-02 | 1.332 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 3.540162e-02 | 1.451 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.846736e-02 | 1.415 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.226812e-02 | 1.282 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 3.690653e-02 | 1.433 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.348644e-02 | 1.362 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.836800e-02 | 1.416 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.198051e-02 | 1.377 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.359153e-02 | 1.361 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.198051e-02 | 1.377 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.342726e-02 | 1.272 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.233801e-02 | 1.205 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.233801e-02 | 1.205 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 6.249680e-02 | 1.204 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.365942e-02 | 1.196 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.365942e-02 | 1.196 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.365942e-02 | 1.196 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.365942e-02 | 1.196 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.365942e-02 | 1.196 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.398225e-02 | 1.194 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.398225e-02 | 1.194 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.398225e-02 | 1.194 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.502201e-02 | 1.187 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.590031e-02 | 1.181 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.590031e-02 | 1.181 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.663513e-02 | 1.176 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.743042e-02 | 1.171 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.817410e-02 | 1.166 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.817410e-02 | 1.166 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.817410e-02 | 1.166 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.864904e-02 | 1.163 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.919539e-02 | 1.160 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.919539e-02 | 1.160 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.919539e-02 | 1.160 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.190015e-02 | 1.143 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.190015e-02 | 1.143 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.190015e-02 | 1.143 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.193990e-02 | 1.143 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.251461e-02 | 1.140 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.251461e-02 | 1.140 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 7.251461e-02 | 1.140 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.477673e-02 | 1.126 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.504065e-02 | 1.125 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.504065e-02 | 1.125 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.504065e-02 | 1.125 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.504065e-02 | 1.125 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.504065e-02 | 1.125 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.637770e-02 | 1.117 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.737075e-02 | 1.111 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.737075e-02 | 1.111 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.836385e-02 | 1.106 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 7.836385e-02 | 1.106 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 7.836385e-02 | 1.106 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 7.836385e-02 | 1.106 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 7.836385e-02 | 1.106 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.836385e-02 | 1.106 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.387313e-02 | 1.076 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.563188e-02 | 1.067 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.641683e-02 | 1.063 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 8.700896e-02 | 1.060 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 8.700896e-02 | 1.060 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.700896e-02 | 1.060 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.700896e-02 | 1.060 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 8.700896e-02 | 1.060 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.891437e-02 | 1.051 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.891437e-02 | 1.051 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.891437e-02 | 1.051 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.891437e-02 | 1.051 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.166926e-02 | 1.038 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.166926e-02 | 1.038 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.361229e-02 | 1.029 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.497935e-02 | 1.022 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.532015e-02 | 1.021 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.862405e-02 | 1.006 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 9.949938e-02 | 1.002 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 9.949938e-02 | 1.002 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 9.949938e-02 | 1.002 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 9.949938e-02 | 1.002 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.949938e-02 | 1.002 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 9.949938e-02 | 1.002 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 9.949938e-02 | 1.002 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.975321e-02 | 1.001 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 1.012339e-01 | 0.995 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.016076e-01 | 0.993 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.024834e-01 | 0.989 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.062280e-01 | 0.974 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.100473e-01 | 0.958 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.120976e-01 | 0.950 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.124512e-01 | 0.949 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.142921e-01 | 0.942 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.142921e-01 | 0.942 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.151616e-01 | 0.939 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.151616e-01 | 0.939 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 1.152153e-01 | 0.938 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 1.152153e-01 | 0.938 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.152153e-01 | 0.938 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.152153e-01 | 0.938 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.152153e-01 | 0.938 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.152153e-01 | 0.938 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.152153e-01 | 0.938 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.152153e-01 | 0.938 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.152153e-01 | 0.938 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.152153e-01 | 0.938 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.169842e-01 | 0.932 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.171838e-01 | 0.931 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 1.171838e-01 | 0.931 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.210854e-01 | 0.917 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 1.210854e-01 | 0.917 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.210854e-01 | 0.917 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.210854e-01 | 0.917 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.219476e-01 | 0.914 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.237700e-01 | 0.907 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.255982e-01 | 0.901 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.258076e-01 | 0.900 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.258076e-01 | 0.900 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.258076e-01 | 0.900 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.260598e-01 | 0.899 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.272190e-01 | 0.895 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.280476e-01 | 0.893 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.280476e-01 | 0.893 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.296343e-01 | 0.887 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.311336e-01 | 0.882 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.346985e-01 | 0.871 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.346985e-01 | 0.871 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.346985e-01 | 0.871 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 1.364874e-01 | 0.865 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.395158e-01 | 0.855 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.395158e-01 | 0.855 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.424555e-01 | 0.846 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.430195e-01 | 0.845 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.432158e-01 | 0.844 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.461362e-01 | 0.835 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.498893e-01 | 0.824 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.505954e-01 | 0.822 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 1.505954e-01 | 0.822 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.505954e-01 | 0.822 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.505954e-01 | 0.822 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.505954e-01 | 0.822 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 1.505954e-01 | 0.822 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.505954e-01 | 0.822 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.505954e-01 | 0.822 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.505954e-01 | 0.822 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.505954e-01 | 0.822 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.535263e-01 | 0.814 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.542979e-01 | 0.812 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.542979e-01 | 0.812 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.568007e-01 | 0.805 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.607490e-01 | 0.794 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.615779e-01 | 0.792 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.615779e-01 | 0.792 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.615779e-01 | 0.792 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.625669e-01 | 0.789 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.632604e-01 | 0.787 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.667504e-01 | 0.778 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.677932e-01 | 0.775 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.677932e-01 | 0.775 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.730357e-01 | 0.762 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.731551e-01 | 0.762 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.739690e-01 | 0.760 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.810117e-01 | 0.742 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 1.822737e-01 | 0.739 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.822737e-01 | 0.739 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.822737e-01 | 0.739 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.822737e-01 | 0.739 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.822737e-01 | 0.739 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.832139e-01 | 0.737 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.845629e-01 | 0.734 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.845629e-01 | 0.734 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.845629e-01 | 0.734 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.845629e-01 | 0.734 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.945389e-01 | 0.711 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.969280e-01 | 0.706 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.969280e-01 | 0.706 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.056305e-01 | 0.687 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.117191e-01 | 0.674 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.117191e-01 | 0.674 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.117191e-01 | 0.674 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.142403e-01 | 0.669 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.142403e-01 | 0.669 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.142403e-01 | 0.669 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.171739e-01 | 0.663 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.171739e-01 | 0.663 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.171739e-01 | 0.663 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.171739e-01 | 0.663 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.171739e-01 | 0.663 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.171739e-01 | 0.663 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.171739e-01 | 0.663 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.171739e-01 | 0.663 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.171739e-01 | 0.663 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.248223e-01 | 0.648 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.248223e-01 | 0.648 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.266127e-01 | 0.645 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.266127e-01 | 0.645 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 2.355030e-01 | 0.628 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.355030e-01 | 0.628 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.379620e-01 | 0.623 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.415770e-01 | 0.617 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.415770e-01 | 0.617 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.415770e-01 | 0.617 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.415770e-01 | 0.617 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.415770e-01 | 0.617 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.415770e-01 | 0.617 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.415770e-01 | 0.617 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.431309e-01 | 0.614 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.462703e-01 | 0.609 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.462703e-01 | 0.609 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.477211e-01 | 0.606 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.484827e-01 | 0.605 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.484827e-01 | 0.605 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.484827e-01 | 0.605 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.484827e-01 | 0.605 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.484827e-01 | 0.605 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.484827e-01 | 0.605 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.484827e-01 | 0.605 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.484827e-01 | 0.605 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.484827e-01 | 0.605 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.484827e-01 | 0.605 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.484827e-01 | 0.605 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.484827e-01 | 0.605 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.484827e-01 | 0.605 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.484827e-01 | 0.605 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.484827e-01 | 0.605 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.513607e-01 | 0.600 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.565827e-01 | 0.591 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.565827e-01 | 0.591 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.571121e-01 | 0.590 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.662659e-01 | 0.575 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.707700e-01 | 0.567 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.716025e-01 | 0.566 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.716025e-01 | 0.566 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.716025e-01 | 0.566 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.725103e-01 | 0.565 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.785411e-01 | 0.555 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.785411e-01 | 0.555 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.785411e-01 | 0.555 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.785411e-01 | 0.555 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.785411e-01 | 0.555 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.785411e-01 | 0.555 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.785411e-01 | 0.555 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.785411e-01 | 0.555 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.785411e-01 | 0.555 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.785411e-01 | 0.555 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.785411e-01 | 0.555 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.785411e-01 | 0.555 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.785411e-01 | 0.555 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.785411e-01 | 0.555 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.789735e-01 | 0.554 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 2.866114e-01 | 0.543 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.866114e-01 | 0.543 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.866114e-01 | 0.543 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 2.877546e-01 | 0.541 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.893518e-01 | 0.539 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.899709e-01 | 0.538 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.932032e-01 | 0.533 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 2.932032e-01 | 0.533 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.996405e-01 | 0.523 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.009985e-01 | 0.521 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.009985e-01 | 0.521 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.009985e-01 | 0.521 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.009985e-01 | 0.521 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.015862e-01 | 0.521 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.015862e-01 | 0.521 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.020650e-01 | 0.520 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.020650e-01 | 0.520 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.022637e-01 | 0.520 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.022637e-01 | 0.520 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.022637e-01 | 0.520 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.022637e-01 | 0.520 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.022637e-01 | 0.520 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 3.022637e-01 | 0.520 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.073991e-01 | 0.512 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.073991e-01 | 0.512 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.073991e-01 | 0.512 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 3.073991e-01 | 0.512 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.073991e-01 | 0.512 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.073991e-01 | 0.512 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.073991e-01 | 0.512 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 3.073991e-01 | 0.512 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.073991e-01 | 0.512 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.113550e-01 | 0.507 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 3.120464e-01 | 0.506 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.165058e-01 | 0.500 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.204713e-01 | 0.494 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.213410e-01 | 0.493 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.213410e-01 | 0.493 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.313506e-01 | 0.480 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.341636e-01 | 0.476 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.351044e-01 | 0.475 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.351044e-01 | 0.475 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.351044e-01 | 0.475 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.351044e-01 | 0.475 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.351044e-01 | 0.475 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 3.351044e-01 | 0.475 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.351044e-01 | 0.475 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.351044e-01 | 0.475 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.351044e-01 | 0.475 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.351044e-01 | 0.475 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.351044e-01 | 0.475 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.351044e-01 | 0.475 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.351044e-01 | 0.475 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.351044e-01 | 0.475 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.389064e-01 | 0.470 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.389064e-01 | 0.470 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.461027e-01 | 0.461 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.461027e-01 | 0.461 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 3.468783e-01 | 0.460 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.562486e-01 | 0.448 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.607460e-01 | 0.443 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.607460e-01 | 0.443 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.607460e-01 | 0.443 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.607460e-01 | 0.443 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.617031e-01 | 0.442 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.617031e-01 | 0.442 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.617031e-01 | 0.442 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.617031e-01 | 0.442 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 3.617031e-01 | 0.442 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.617031e-01 | 0.442 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.617031e-01 | 0.442 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.617031e-01 | 0.442 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.617031e-01 | 0.442 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.617031e-01 | 0.442 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.617031e-01 | 0.442 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.657251e-01 | 0.437 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.672575e-01 | 0.435 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.672575e-01 | 0.435 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.752654e-01 | 0.426 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.752654e-01 | 0.426 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.752654e-01 | 0.426 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 3.782334e-01 | 0.422 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.868335e-01 | 0.412 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.872393e-01 | 0.412 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.872393e-01 | 0.412 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.872393e-01 | 0.412 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.872393e-01 | 0.412 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.872393e-01 | 0.412 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.872393e-01 | 0.412 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.872393e-01 | 0.412 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.872393e-01 | 0.412 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.872393e-01 | 0.412 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.872393e-01 | 0.412 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.896476e-01 | 0.409 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.896476e-01 | 0.409 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.896476e-01 | 0.409 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.896476e-01 | 0.409 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.896476e-01 | 0.409 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.936559e-01 | 0.405 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 3.958867e-01 | 0.402 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.000559e-01 | 0.398 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.038802e-01 | 0.394 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.038802e-01 | 0.394 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.038802e-01 | 0.394 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.038802e-01 | 0.394 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.038802e-01 | 0.394 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.117553e-01 | 0.385 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.117553e-01 | 0.385 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.117553e-01 | 0.385 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.117553e-01 | 0.385 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.117553e-01 | 0.385 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.117553e-01 | 0.385 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 4.117553e-01 | 0.385 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.117553e-01 | 0.385 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.117553e-01 | 0.385 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 4.117553e-01 | 0.385 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 4.187123e-01 | 0.378 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.318539e-01 | 0.365 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.318539e-01 | 0.365 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.318539e-01 | 0.365 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.323639e-01 | 0.364 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.327506e-01 | 0.364 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.352919e-01 | 0.361 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 4.352919e-01 | 0.361 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.352919e-01 | 0.361 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.352919e-01 | 0.361 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.352919e-01 | 0.361 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.352919e-01 | 0.361 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.352919e-01 | 0.361 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 4.388831e-01 | 0.358 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.429947e-01 | 0.354 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.429947e-01 | 0.354 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.445499e-01 | 0.352 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.455762e-01 | 0.351 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.455762e-01 | 0.351 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.455762e-01 | 0.351 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 4.455762e-01 | 0.351 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.478202e-01 | 0.349 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.535468e-01 | 0.343 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.535468e-01 | 0.343 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 4.567122e-01 | 0.340 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 4.578882e-01 | 0.339 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.578882e-01 | 0.339 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.578882e-01 | 0.339 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.578882e-01 | 0.339 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.578882e-01 | 0.339 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.578882e-01 | 0.339 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.578882e-01 | 0.339 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.578882e-01 | 0.339 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.578882e-01 | 0.339 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.578882e-01 | 0.339 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.578882e-01 | 0.339 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.581326e-01 | 0.339 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.659318e-01 | 0.332 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.724521e-01 | 0.326 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.724521e-01 | 0.326 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.724521e-01 | 0.326 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.724521e-01 | 0.326 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.724521e-01 | 0.326 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.728146e-01 | 0.325 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.736967e-01 | 0.324 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.754545e-01 | 0.323 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.795816e-01 | 0.319 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.795816e-01 | 0.319 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.795816e-01 | 0.319 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.795816e-01 | 0.319 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.795816e-01 | 0.319 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.795816e-01 | 0.319 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.795816e-01 | 0.319 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.795816e-01 | 0.319 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.795816e-01 | 0.319 | 0 | 0 |
| Acetylation | R-HSA-156582 | 4.795816e-01 | 0.319 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.795816e-01 | 0.319 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.795816e-01 | 0.319 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.795816e-01 | 0.319 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.795816e-01 | 0.319 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.795816e-01 | 0.319 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.795816e-01 | 0.319 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.795816e-01 | 0.319 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.795816e-01 | 0.319 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.795816e-01 | 0.319 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.814250e-01 | 0.317 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.846808e-01 | 0.315 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.855926e-01 | 0.314 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.855926e-01 | 0.314 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.855926e-01 | 0.314 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.937451e-01 | 0.306 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.948696e-01 | 0.306 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.985275e-01 | 0.302 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.004082e-01 | 0.301 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.004082e-01 | 0.301 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.004082e-01 | 0.301 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.004082e-01 | 0.301 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.004082e-01 | 0.301 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.004082e-01 | 0.301 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 5.143924e-01 | 0.289 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.149391e-01 | 0.288 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.149391e-01 | 0.288 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.149391e-01 | 0.288 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.204025e-01 | 0.284 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.204025e-01 | 0.284 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.204025e-01 | 0.284 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 5.204025e-01 | 0.284 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.204025e-01 | 0.284 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.204025e-01 | 0.284 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.204025e-01 | 0.284 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.204025e-01 | 0.284 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.204025e-01 | 0.284 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.237626e-01 | 0.281 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.237626e-01 | 0.281 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.237626e-01 | 0.281 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 5.242885e-01 | 0.280 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 5.242885e-01 | 0.280 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.248127e-01 | 0.280 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.345747e-01 | 0.272 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.345747e-01 | 0.272 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 5.360558e-01 | 0.271 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.360558e-01 | 0.271 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.360558e-01 | 0.271 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.395978e-01 | 0.268 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.395978e-01 | 0.268 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.395978e-01 | 0.268 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.395978e-01 | 0.268 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.395978e-01 | 0.268 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.395978e-01 | 0.268 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.414531e-01 | 0.266 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.442222e-01 | 0.264 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.481290e-01 | 0.261 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 5.481290e-01 | 0.261 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.580260e-01 | 0.253 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.580260e-01 | 0.253 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.580260e-01 | 0.253 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.580260e-01 | 0.253 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.580260e-01 | 0.253 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.580260e-01 | 0.253 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.580260e-01 | 0.253 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.580260e-01 | 0.253 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.580260e-01 | 0.253 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.599802e-01 | 0.252 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.631633e-01 | 0.249 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.716077e-01 | 0.243 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.716077e-01 | 0.243 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.716077e-01 | 0.243 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.716077e-01 | 0.243 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.716077e-01 | 0.243 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.716077e-01 | 0.243 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.757176e-01 | 0.240 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.757176e-01 | 0.240 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.757176e-01 | 0.240 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.757176e-01 | 0.240 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.757176e-01 | 0.240 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.757176e-01 | 0.240 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.760331e-01 | 0.240 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.830105e-01 | 0.234 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.830105e-01 | 0.234 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.906579e-01 | 0.229 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.915598e-01 | 0.228 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.927021e-01 | 0.227 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 5.941879e-01 | 0.226 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.981356e-01 | 0.223 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.995711e-01 | 0.222 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 6.025777e-01 | 0.220 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.051397e-01 | 0.218 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.051397e-01 | 0.218 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.051397e-01 | 0.218 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.057521e-01 | 0.218 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.090077e-01 | 0.215 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.090077e-01 | 0.215 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.090077e-01 | 0.215 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.090077e-01 | 0.215 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.090077e-01 | 0.215 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 6.123360e-01 | 0.213 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.132800e-01 | 0.212 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.170117e-01 | 0.210 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.246614e-01 | 0.204 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.246614e-01 | 0.204 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.246614e-01 | 0.204 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.246614e-01 | 0.204 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.246614e-01 | 0.204 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.246614e-01 | 0.204 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.246614e-01 | 0.204 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.246614e-01 | 0.204 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.246614e-01 | 0.204 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.246614e-01 | 0.204 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 6.255370e-01 | 0.204 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.263675e-01 | 0.203 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.339312e-01 | 0.198 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.353229e-01 | 0.197 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.353229e-01 | 0.197 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.366448e-01 | 0.196 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.396894e-01 | 0.194 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.396894e-01 | 0.194 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.396894e-01 | 0.194 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.396894e-01 | 0.194 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.396894e-01 | 0.194 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.396894e-01 | 0.194 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.396894e-01 | 0.194 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.396894e-01 | 0.194 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.396894e-01 | 0.194 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.466990e-01 | 0.189 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.541166e-01 | 0.184 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 6.541166e-01 | 0.184 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.541166e-01 | 0.184 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.565316e-01 | 0.183 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 6.567521e-01 | 0.183 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.661442e-01 | 0.176 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.679669e-01 | 0.175 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.679669e-01 | 0.175 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.679669e-01 | 0.175 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.679669e-01 | 0.175 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.679669e-01 | 0.175 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.705847e-01 | 0.174 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.787438e-01 | 0.168 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.812634e-01 | 0.167 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.812634e-01 | 0.167 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.812634e-01 | 0.167 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.812634e-01 | 0.167 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.812634e-01 | 0.167 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.812634e-01 | 0.167 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.812634e-01 | 0.167 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.812634e-01 | 0.167 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.812634e-01 | 0.167 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.815193e-01 | 0.167 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.816014e-01 | 0.166 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.847168e-01 | 0.164 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.847168e-01 | 0.164 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.940282e-01 | 0.159 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.940282e-01 | 0.159 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 6.940282e-01 | 0.159 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.940282e-01 | 0.159 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 6.940282e-01 | 0.159 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.940282e-01 | 0.159 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.024341e-01 | 0.153 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.024341e-01 | 0.153 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.035259e-01 | 0.153 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 7.062826e-01 | 0.151 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.062826e-01 | 0.151 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.062826e-01 | 0.151 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.062826e-01 | 0.151 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.062826e-01 | 0.151 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.062826e-01 | 0.151 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.109780e-01 | 0.148 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.180469e-01 | 0.144 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.180469e-01 | 0.144 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.180469e-01 | 0.144 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.180469e-01 | 0.144 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.180469e-01 | 0.144 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.180469e-01 | 0.144 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 7.274500e-01 | 0.138 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.293406e-01 | 0.137 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.293406e-01 | 0.137 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.293406e-01 | 0.137 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.293406e-01 | 0.137 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.293406e-01 | 0.137 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.293406e-01 | 0.137 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.293406e-01 | 0.137 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.310367e-01 | 0.136 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.401827e-01 | 0.131 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.401827e-01 | 0.131 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.401827e-01 | 0.131 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.401827e-01 | 0.131 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.431200e-01 | 0.129 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.442740e-01 | 0.128 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.505911e-01 | 0.125 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.505911e-01 | 0.125 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.505911e-01 | 0.125 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.505911e-01 | 0.125 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.580122e-01 | 0.120 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.580122e-01 | 0.120 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 7.580297e-01 | 0.120 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.605831e-01 | 0.119 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.605831e-01 | 0.119 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.605831e-01 | 0.119 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.605831e-01 | 0.119 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.651746e-01 | 0.116 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.651746e-01 | 0.116 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.701754e-01 | 0.113 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.701754e-01 | 0.113 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.701754e-01 | 0.113 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.701754e-01 | 0.113 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.701754e-01 | 0.113 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.701754e-01 | 0.113 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.701754e-01 | 0.113 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.721523e-01 | 0.112 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.789484e-01 | 0.108 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.793840e-01 | 0.108 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 7.882241e-01 | 0.103 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.882241e-01 | 0.103 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.882241e-01 | 0.103 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.882241e-01 | 0.103 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 7.910099e-01 | 0.102 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.920094e-01 | 0.101 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.920094e-01 | 0.101 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.967105e-01 | 0.099 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.982811e-01 | 0.098 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.048573e-01 | 0.094 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.048573e-01 | 0.094 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.103237e-01 | 0.091 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.107578e-01 | 0.091 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.126782e-01 | 0.090 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.126782e-01 | 0.090 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.126782e-01 | 0.090 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.126782e-01 | 0.090 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.161014e-01 | 0.088 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.201860e-01 | 0.086 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.201860e-01 | 0.086 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.201860e-01 | 0.086 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.201860e-01 | 0.086 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.201860e-01 | 0.086 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 8.201860e-01 | 0.086 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.273934e-01 | 0.082 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.343123e-01 | 0.079 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.343123e-01 | 0.079 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.376666e-01 | 0.077 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.409543e-01 | 0.075 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.473304e-01 | 0.072 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.473304e-01 | 0.072 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.475687e-01 | 0.072 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.498057e-01 | 0.071 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.498057e-01 | 0.071 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.534512e-01 | 0.069 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.534512e-01 | 0.069 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 8.534512e-01 | 0.069 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.534512e-01 | 0.069 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.534512e-01 | 0.069 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.593270e-01 | 0.066 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.597899e-01 | 0.066 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.649676e-01 | 0.063 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.649676e-01 | 0.063 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.649676e-01 | 0.063 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.649676e-01 | 0.063 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.649676e-01 | 0.063 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.703823e-01 | 0.060 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.728547e-01 | 0.059 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.755803e-01 | 0.058 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.755803e-01 | 0.058 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.805700e-01 | 0.055 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.853600e-01 | 0.053 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.856590e-01 | 0.053 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.899581e-01 | 0.051 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.899581e-01 | 0.051 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.967738e-01 | 0.047 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.986093e-01 | 0.046 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.986093e-01 | 0.046 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.987059e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.065813e-01 | 0.043 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.096202e-01 | 0.041 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.103294e-01 | 0.041 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.202175e-01 | 0.036 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.206965e-01 | 0.036 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.269341e-01 | 0.033 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.298667e-01 | 0.032 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.310683e-01 | 0.031 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.324387e-01 | 0.030 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.326817e-01 | 0.030 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.379779e-01 | 0.028 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.428580e-01 | 0.026 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.440464e-01 | 0.025 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.451523e-01 | 0.024 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.473546e-01 | 0.023 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.595433e-01 | 0.018 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.604868e-01 | 0.018 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.604868e-01 | 0.018 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.620212e-01 | 0.017 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.620742e-01 | 0.017 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.635979e-01 | 0.016 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.644216e-01 | 0.016 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.650604e-01 | 0.015 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.650604e-01 | 0.015 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.664643e-01 | 0.015 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.680289e-01 | 0.014 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.701664e-01 | 0.013 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.703469e-01 | 0.013 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.703469e-01 | 0.013 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.715368e-01 | 0.013 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.715387e-01 | 0.013 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.715387e-01 | 0.013 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.737807e-01 | 0.012 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.788584e-01 | 0.009 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.795027e-01 | 0.009 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.795027e-01 | 0.009 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.826064e-01 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.826064e-01 | 0.008 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.832299e-01 | 0.007 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.876912e-01 | 0.005 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.883862e-01 | 0.005 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.919344e-01 | 0.004 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.922788e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.932646e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.935110e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.937344e-01 | 0.003 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.951645e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.976803e-01 | 0.001 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.976940e-01 | 0.001 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.978174e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.981882e-01 | 0.001 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.983620e-01 | 0.001 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.986421e-01 | 0.001 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.990630e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.994954e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.997600e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.997791e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.998346e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998812e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998906e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999373e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999657e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999894e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999940e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999978e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999978e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
